The histaminergic neurotransmitter system : its development and role in neuronal plasticity in zebrafish, Danio rerio by Sundvik, Maria
  
 
 
The histaminergic neurotransmitter system  
– its development and role in neuronal plasticity in 
zebrafish, Danio rerio 
 
 
Jenny Maria Sundvik 
 
Neuroscience Center and  
Institute of Biomedicine, Anatomy 
Faculty of Medicine 
University of Helsinki 
Finland 
 
and 
 
Helsinki Biomedical Graduate Program 
 
 
 
 
 
 
ACADEMIC DISSERTATION 
To be publicly discussed with the permission of the Faculty of Medicine, University 
of Helsinki, in Lecture Hall 2, Haartman Institute, Haartmaninkatu 3,  
on August 24
th
 2012, at 12 noon. 
Helsinki 2012  
  
 
Supervised by 
Professor Pertti Panula 
Neuroscience Center and Institute of Biomedicine, Anatomy 
Faculty of Medicine 
University of Helsinki 
Finland 
 
Thesis committee 
Professor Esa Korpi 
Institute of Biomedicine, Pharmacology 
Faculty of Medicine 
University of Helsinki 
Finland 
Dr. Tarja Stenberg 
Institute of Biomedicine, Physiology 
Faculty of Medicine 
University of Helsinki 
Finland 
 
Reviewed by 
Assistant Professor Sanna Lehtonen 
Haartman Institute, Pathology 
Faculty of Medicine 
University of Helsinki 
Finland 
 
Assistant Professor Niclas Kolm 
Department of Ecology and 
Evolution, Animal Ecology 
Evolutionary Biology Center 
Uppsala University 
Sweden 
 
Opponent 
Dr. Catherina Becker 
Center for Neuroregeneration 
The University of Edinburgh 
United Kingdom 
 
 
© Maria Sundvik 2012 
ISBN 978-952-10-8136-1 (paperback) 
ISBN 978-952-10-8137-8 (PDF) 
http://ethesis.helsinki.fi 
Unigrafia, Helsinki University Print 
Helsinki 2012  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my family 
  
  
 
 
  
 
Table of contents 
List of original publications........................................................................................................... 7 
Author contribution ......................................................................................................................... 7 
Abstract .................................................................................................................................................. 8 
Abbreviations ................................................................................................................................... 10 
1 Introduction .................................................................................................................................. 12 
2 Review of the literature ........................................................................................................... 14 
2.1 Neuronal networks and plasticity ............................................................................... 14 
2.1.1 Aminergic neurotransmitter systems............................................................... 15 
2.1.2 Development of the histaminergic neurotransmitter system ............... 16 
2.1.3 Synthesis, storage, release, and catabolism of the aminergic 
neurotransmitters .................................................................................................... 17 
2.1.4 Histaminergic receptor-signaling system ....................................................... 19 
2.2 Neurotransmitter systems under normal conditions and disease ............... 21 
2.2.1 Alertness and wakefulness .................................................................................... 21 
2.2.2 Histamine and neurodegenerative diseases .................................................. 22 
2.3 Zebrafish as a vertebrate model organism ............................................................. 25 
2.3.1 Comparative neuroanatomy of fish and mammals ..................................... 26 
2.3.2 Zebrafish behavior and motor functions ......................................................... 28 
2.3.3 Behavioral pharmacology ...................................................................................... 30 
2.3.4 Modification of gene expression with morpholino  
oligonucleotides ........................................................................................................ 31 
2.3.5 Modification of gene expression by inducing mutations into the  
genome .......................................................................................................................... 31 
2.3.6 Spatially and temporally targeted gene expression ................................... 32 
2.3.7 Appropriateness of modeling human disease in a simple  
vertebrate .................................................................................................................... 33 
3 Aims of the study ........................................................................................................................ 34 
4 Methods ........................................................................................................................................... 35 
4.1 Animals ................................................................................................................................... 35 
4.2 Manipulation of gene expression by morpholino oligonucleotides (III) ... 35 
4.3 Pharmacological treatments ......................................................................................... 35 
4.3.1 Treatment with histamine receptor ligands or α-
fluoromethylhistidine (III) ................................................................................... 36 
4.3.2 Deprenyl, p-chlorophenylalanine, and fluvoxamine treatments (V) .. 36 
4.3.3 γ-Secretase inhibitor DAPT treatments (IV).................................................. 36 
4.4 Behavioral tests ................................................................................................................... 37 
4.4.1 Locomotor activity of zebrafish (I, III–V) ........................................................ 37 
4.4.2 Place preference (IV) ............................................................................................... 37 
4.4.3 Place preference in a water column (V) .......................................................... 37 
4.4.4 Locomotor activity of larval zebrafish over a 24-h period (III) ............ 38 
4.4.5 Dark-induced flash responses in larval zebrafish (III, IV) ....................... 38 
4.4.6 Optomotor response (III) ....................................................................................... 38 
4.5 Lipophilic dye DiI tracing (III) ...................................................................................... 38 
  
 
4.6 Real-time polymerase chain reaction ........................................................................ 39 
4.6.1 Cloning of zebrafish hrh1, hrh2, and hrh3 receptors in adult 
zebrafish (I) ................................................................................................................. 39 
4.6.2 Expression of hrh1, hrh2, and hrh3 mRNA (I) .............................................. 39 
4.6.3 Cloning full-length hdc cDNA and synthesis of capped  
hdc mRNA (III) ........................................................................................................... 39 
4.6.4 Quantitative real-time polymerase chain reaction (III, IV) ..................... 40 
4.6.5 Touchdown RT-PCR for identification of mutation in psen1-/- (IV) .. 40 
4.7 Sequence comparisons and analysis of histamine receptors (I) ................... 41 
4.8 [125I]iodoaminopotentidine binding to hrh2 (I) ................................................... 41 
4.9 Whole-mount in situ hybridization (III, IV) ............................................................ 41 
4.10 Immunohistochemistry (II–V) ................................................................................... 42 
4.10.1 IHC with antibodies from different species on whole-mount larval 
brains (II–V) ................................................................................................................ 42 
4.10.2 IHC on whole-mount adult brains (II, IV) ..................................................... 42 
4.10.3 IHC with two antibodies from the same species on cryosections 
 (II, III) ............................................................................................................................ 43 
4.10.4 Enzyme histochemistry and activity assay (V) .......................................... 44 
4.11 High-pressure liquid chromatography .................................................................. 44 
4.11.1 Catecholamine and serotonin HPLC (V) ....................................................... 44 
4.11.2 Histamine HPLC (III) ............................................................................................. 44 
4.12 Microscopy ......................................................................................................................... 44 
4.13 Image analysis ................................................................................................................... 45 
4.14 Statistical methods .......................................................................................................... 46 
5 Results ............................................................................................................................................. 47 
5.1 Identification and characterization of the histamine receptors in 
zebrafish and the behavioral effects of their ligands (I, III) ............................ 47 
5.2 Cotransmitters of the histaminergic neurons (II, III) ......................................... 48 
5.3 Histaminergic system in alertness/wakefulness (III) ........................................ 49 
5.4 γ-Secretase regulates the development of histamine neurons (IV) ............. 50 
5.5 Neuronal plasticity and the histamine system (III, IV) ...................................... 52 
5.6 Monoamine oxidase affects locomotor activity via serotonin (V) ................ 54 
6 Discussion ...................................................................................................................................... 56 
6.1 The methods – drawbacks and strengths ................................................................ 56 
6.2 Neuronal circuits underlying behavior (III, V) ...................................................... 57 
6.3 The histaminergic system in zebrafish compared with that in  
mammals (I–III) .................................................................................................................. 59 
6.4 The potential role of histamine in neurodegenerative disease (III, IV) ..... 63 
7 Conclusions .................................................................................................................................... 66 
8 Future prospects ......................................................................................................................... 68 
Acknowledgements ....................................................................................................................... 70 
References ......................................................................................................................................... 72 
 
APPENDIX Original publications 
 
 7 
 
List of original publications 
I Peitsaro N, Sundvik M, Anichtchik OV, Kaslin J, Panula P, 2007, 
“Identification of zebrafish histamine H1, H2 and H3 receptors and effects of 
histaminergic ligands on behavior”, Biochemical Pharmacology, vol. 73, no. 
8, pp. 1205-1214.  
II  Sundvik M, Panula P, 2012, “The organization of the histaminergic system in 
adult zebrafish (Danio rerio) brain: neuron number, location and co-
transmitters”, Journal of Comparative Neurology, accepted for publication. 
III  Sundvik M, Kudo H, Toivonen P, Rozov S, Chen YC, Panula P, 2011, “The 
histaminergic system regulates wakefulness and orexin/hypocretin neuron 
development via histamine H1 receptor in zebrafish”, The FASEB Journal, 
vol. 25, vol. 12, pp. 4338-4347. 
IV  Sundvik M, Chen YC, Panula P, “Presenilin1 regulates histamine neuron 
development and behavior in zebrafish, Danio rerio”, submitted. 
V Sallinen V, Sundvik M, Reenilä I, Peitsaro N, Khrustalyov D, Anichtchik O, 
Toleikyte G, Kaslin J, Panula P, 2009, “Hyperserotonergic phenotype after 
monoamine oxidase inhibition in larval zebrafish”, Journal of 
Neurochemistry, vol. 109, no. 2, pp. 403-415. This publication is included in 
Dr. Ville Sallinen’s doctoral thesis. 
Author contribution 
I Sundvik set up a method for assessing behavior in larval zebrafish, designed 
the behavioral experiment, conducted it, and analyzed the results. 
II Sundvik designed the study partially, conducted all experiments, analyzed 
the data, and wrote the manuscript. 
III Sundvik set up behavioral methods for zebrafish larvae, conducted the 
behavioral, molecular, and immunohistological studies, analyzed the results, 
and wrote the manuscript.  
IV Sundvik established the association between the histaminergic system and 
psen1, designed the study, carried out the experiments, and wrote the 
manuscript.  
V Sundvik set up a method for assessing behavior in larval zebrafish, designed 
the behavioral experiments, conducted them, analyzed the results, and took 
part in writing the manuscript. 
 8 
 
Abstract  
The histaminergic neurotransmitter system is a modulatory system which 
regulates many functions in the vertebrate brain. In the mammalian brain, 
histaminergic neurons fire during waking and are involved in maintaining sleep-
wake homeostasis. Furthermore, histamine has been implicated in 
neurodegenerative disorders as resulting from either up- or downregulation of the 
neurotransmitter system and has been detected in patients suffering from 
Alzheimer’s disease, Parkinson’s disease, and narcolepsy. Histamine is produced 
from the amino acid ι-histidine by histidine decarboxylase (HDC). The aims of this 
study were to characterize the histaminergic system in zebrafish, a nonmammalian 
vertebrate, and to identify novel mechanisms that are mediated by the 
histaminergic system.  
We found that histamine receptor ligands altered the behavior in larval zebrafish 
in a dose-dependent manner. Cloning and sequence analysis of the histaminergic 
receptors indicated that the zebrafish histamine receptors were similar to the 
corresponding mammalian receptors. We also studied the neurotransmitter 
phenotype of histaminergic neurons by immunohistochemistry and confocal 
microscopy and found that these neurons resemble those of rats. 
Immunohistochemical comparison of the histaminergic system in male and female 
adult brain revealed no significant differences in location, distribution, or neuron 
number, and thereby no differences between the sexes were observed. We 
studied the functioning of the histaminergic system in hdc knockdown animals 
(morpholino oligonucleotide approach), and found that the neurotransmitter was 
important for mediating rapid behavioral responses to environmental cues, and 
that these behavioral responses were driven via the histamine receptor, hrh1. We 
studied the interaction of histamine with a wakefulness associated neuropeptide 
system, hypocretin/orexin (hcrt), which is implicated in narcolepsy. We reported a 
novel mechanism for histamine that regulates development of hcrt neurons. 
Transient knockdown of hdc with morpholino oligonucleotides and 
pharmacological inactivation of hrh1 with pyrilamine reduced the number of hcrt 
mRNA-positive neurons in zebrafish larvae. This effect was rescued by 
overexpression of hdc mRNA. Since histaminergic neurons play important roles in 
the central nervous system, we were interested in identifying a factor that 
regulates the development of the histaminergic neurons themselves. We found 
that in the Alzheimer’s disease-associated gene, presenilin1 (psen1), mutant 
zebrafish, the histaminergic system was altered. During the developmental and 
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larval stages, the histamine neuron number was significantly reduced in psen1 
mutants, whereas at the young adult age there was a significant increase in 
histamine neuron number in psen1 mutants in comparison to wild-type fish. These 
results showed us that psen1 was essential for the development and normal 
functioning of the histaminergic neurotransmitter system. Histamine is 
metabolized by histamine N-methyltransferase (HNMT), followed by monoamine 
oxidase (MAO). We studied the effect that pharmacological inhibition of MAO has 
on the locomotor behavior of fish. We found that pharmacological inhibition of the 
MAO enzyme mainly affects the serotonin system in zebrafish, with characteristic 
behavioral consequences that could be rescued.  
Taken together, the results compiled in this thesis provide evidence that the 
histaminergic neurotransmitter system in zebrafish is similar to that in mammals. 
These results show that the zebrafish is an excellent tool in studies that provide 
novel insights into neurotransmitter system functions in the vertebrate central 
nervous system on both the mechanistic and behavioral levels. We found that the 
histaminergic system is important for rapid behavioral responses, affects the 
development of the hcrt neurotransmitter system, and is itself regulated in a 
temporal manner by psen1.   
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1 Introduction 
The basis of modern neuroscience was laid about a century ago when the Spanish 
neuroanatomist Santiago Ramon y Cajal suggested that neurons are the 
anatomical and functional units that together form the central nervous system 
(CNS). His work focused on the structure and organization of the CNS and 
contributed to the acceptance of the neuron doctrine. The neuron doctrine states 
that neurons are the fundamental structural and functional units of the CNS, are 
distinct units that are comprised of dendrites, somata, and axons, and that 
information flows along the neuron from dendrites to axon. Specific behaviors are 
produced by integration of neuronal networks and sensory inputs. Failure to 
produce appropriate responses to certain environmental stimuli can be 
detrimental for the individual. Hence, it is of the outmost importance that the 
individual responds in a correct way. Coordination of all the neurons in the CNS is a 
complex task and therefore elucidating how these networks of molecular and 
neuronal mechanisms interact is a field of constant study and holds many 
unrevealed aspects. 
The histaminergic system is linked to many neuronal pathways and, by interaction 
with receptors in different brain areas, is involved in several complex behaviors, 
from hormonal control to cognition. Although the histaminergic system has been 
studied for decades, the development of the neurons and the exact functions and 
molecular mechanisms of the interactions with other neurotransmitter systems 
are still poorly understood. Diseases in which the histaminergic system has been 
implicated are Alzheimer’s disease (AD), Parkinson’s disease (PD), schizophrenia, 
narcolepsy, and epilepsy. Whether the histaminergic system is involved in the 
pathogenesis of these diseases is still unknown. An analysis of linkage in a two-
generation pedigree showed that a mutation in histidine decarboxylase (hdc), the 
rate-limiting enzyme in histamine synthesis, is associated with Tourette’s 
syndrome (Ercan-Sencicek et al. 2010). This is the first evidence that histamine is 
indeed associated with the etiology of a specific disease. These results open an 
avenue for speculations and one might argue that histamine plays a crucial role in 
modulating and fine-tuning of motor functions. If this is the case, this could 
partially explain why the histaminergic transmission and system is altered in 
diseases that affect motor functioning, such as in PD. In PD, cognitive impairments 
are also evident. Taken together, it is still unclear why the histaminergic system is 
altered in diseases with cognitive decline, such as AD and PD, in the sleep disorder 
Introduction 
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narcolepsy, or in alertness- and neuronal excitability-associated diseases such as 
schizophrenia and epilepsy, respectively. Although the role of histamine in 
neuronal plasticity, e.g. during neurodegeneration, has been studied, there are still 
many unanswered questions to be solved. 
In this thesis, I addressed the factors that affect the development of the 
histaminergic system and how this system contributes to mediating of specific 
behaviors. I set out to study the neuronal histaminergic system in a vertebrate 
species, the zebrafish Danio rerio. The zebrafish has, during the recent decades, 
emerged as a highly suitable vertebrate model for biomedical and neuroscientific 
research, due to its main features: ex utero development, amenability to genetic 
manipulation, and cost-effectiveness. Neuronal and molecular networks 
underlying behaviors have been studied successfully in the invertebrates 
Caenorhabditis elegans and Drosophila melanogaster, and vertebrate model 
organisms, but some unanswered questions still remain.  
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2 Review of the literature 
One of the many challenges in the field of medicine is the identification of specific 
connections of neuronal networks that underlie and mediate specific behaviors. 
Since the human brain is formed of billions of neurons, it is challenging to pinpoint 
the changes in neuronal pathways and the exact mechanisms mediating different 
behaviors. Addressing these questions in a vertebrate model organism with lower 
neuronal complexity, i.e. the zebrafish, has therefore emerged as an attractive 
alternative approach.  
2.1 Neuronal networks and plasticity 
Neuronal networks, in the biological sense, are those that specific pools of neurons 
form with each other to execute certain physiological functions. The ability of the 
individual to adapt to a changed environment, as well as the capacity to learn and 
remember, are dependent on how well the nervous system is able to form new 
and undo old connections, defined as neuronal plasticity. The concept of neuronal 
plasticity was initially described in 1890 by James, and the concept was later 
refined by several scientists, including Cajal and Hebb (as cited in Berlucchi & 
Buchtel 2009). The connections between neurons are formed by specialized 
junctions, i.e. synapses. Strengthening or weakening of the synapses and neuronal 
circuits underlie learning and memory (Kandel, Schwartz & Jessell 1991). 
Alterations in the morphology of the synapses have also been linked to 
neurological disorders (Penzes et al. 2011). 
The neuronal circuits that underlie behavior in mammals have been extensively 
characterized, but the roles of individual neurons in bringing bout precise 
behaviors remain to be elucidated (Kandel, Schwartz & Jessell 1991). Behaviors can 
vary from simple reflexes to those that require the cooperation of several brain 
areas such as the brainstem, telencephalon, cerebellum, basal ganglia, and/or 
thalamus (Figure 1). The cortico-striato-thalamic system and cerebellum therefore 
control and modulate the functions of the upper motor neurons in mammals. The 
release of acetylcholine from the α-motor neurons at myoneuronal junctions 
induces muscle contraction and the produced behavior can be recorded. A new 
cycle is initiated when somatosensory receptors are activated and the newly 
generated information is processed through the spinal cord via modulatory 
systems to the motor cortex.  
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Figure 1. Neuronal circuits that underlie behavior (modified from Kandel, Schwartz & 
Jessell 1991). The neuronal pathways that underlie behavior are organized in a hierarchical 
manner. The cerebral cortex is the master regulator, integrating motor output control and 
somatosensory information. Behaviors can be modulated by the thalamus, basal ganglia, 
cerebellum, brain stem, and spinal cord. Dotted lines indicate the connections known in 
mammals but still unknown in zebrafish. 
2.1.1 Aminergic neurotransmitter systems 
Histamine belongs to the group of biogenic amines, together with dopamine, 
serotonin, adrenaline, and noradrenaline (Figure 2). These neurotransmitter 
systems constitute together with γ-aminobutyric acid (GABA) and glutamate, the 
classical neurotransmitter systems and networks in the brain. All these 
neurotransmitter systems interact to produce complex behaviors such as cognition 
and movement, and regulate wake-sleep states (Saper, Scammell & Lu 2005, Haas, 
Sergeeva & Selbach 2008, Eriksson et al. 2010). The amines are modulatory 
transmitters, since they in general alter the excitability of neurons that are either 
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excitatory or inhibitory, and mainly exert their actions through volume 
transmission (Agnati et al. 1995, Cragg et al. 2001).  
 
Figure 2. Chemical structure of the aminergic neurotransmitters histamine, serotonin, and 
dopamine. 
Histamine, a biogenic amine, was discovered by Dale and Laidlaw in 1910 and is 
one of the phylogenetically oldest neurotransmitters. The first indication that 
histamine functions as a neurotransmitter was by the French professor Schwartz in 
1970 when he identified the properties and distribution of the histamine 
producing enzyme HDC in the rat brain (Schwartz, Lampart & Rose 1970). 
Histaminergic neurons were later identified in the tuberomammillary nucleus 
(TMN) in the posterior part of the hypothalamus in rat brain independently by two 
research groups in 1984 (Panula, Yang & Costa 1984, Watanabe et al. 1984). In the 
periphery of the body, histamine is the main mediator of allergic responses acting 
through histamine receptor subtype 1 (hrh1). Histamine is involved in an array of 
different physiological functions and states, ranging from cognition to hormonal 
homeostasis (Haas & Panula 2003, Haas, Sergeeva & Selbach 2008). It was only 
recently that a strong association of the neurotransmitter system with a specific 
human neuronal disease, Tourette’s syndrome, was established (Ercan-Sencicek et 
al. 2010) and shown to be hrh1-mediated (Fernandez et al. 2011). In zebrafish, the 
role of histamine has lately been studied in dominance and aggression (Filby et al. 
2010, Norton et al. 2011, Pavlidis et al. 2011).  
2.1.2 Development of the histaminergic neurotransmitter system 
The development of the histaminergic system has been studied in several species, 
including zebrafish. In the developing rat brain, histamine is transiently expressed 
in the serotonergic raphe nucleus (Vanhala, Yamatodani & Panula 1994). In 
zebrafish, the first histaminergic neurons appear in the ventral hypothalamus at 3 
days postfertilization (dpf) and efferent projections from these neurons innervate 
the dorsal telencephalon by 4 dpf (Eriksson et al. 1998). The histaminergic system 
consists of a relatively small, specific, and localized neuron population in the 
posterior part of the hypothalamus in zebrafish, and no transient system has been 
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detected (Eriksson et al. 1998) as in mammals. Considering that the histaminergic 
system consists only of a few neurons in the larval zebrafish, the fiber projections 
that arise from these neurons are quite elaborate. A detailed study of the intact 
fiber network could reveal the precise three-dimensional (3D) innervation 
patterns. Although histamine is involved in and regulates many physiological 
functions, the factors that regulate the development of this system are not known. 
2.1.3 Synthesis, storage, release, and catabolism of the aminergic 
neurotransmitters 
Histamine is derived from ι-histidine by HDC (EC 4.1.1.22) (Garbarg et al. 1974) and 
is packed into vesicles by vesicular monoamine transporter 2 (VMAT2) (Figure 3) 
(Merickel & Edwards 1995). After release of histamine into the extracellular space, 
histamine is bound to its receptors or inactivated by methylation into tele-
methylhistamine, a process that is mediated via histamine N-methyltransferase 
(HNMT, EC 2.1.1.8) (Brown, Tomchick & Axelrod 1959). Tele-methylhistamine is 
further oxidized by monoamine oxidase (MAO, EC 1.4.3.4) to methylimidazole 
acetaldehyde (Hough & Domino 1979). Two forms of MAO are known, of which 
MAO-A metabolizes serotonin (Nicotra et al. 2004) and MAO-B metabolizes 
histamine (Schwartz et al. 1991). As in other species, MAO in zebrafish is also 
found in the histaminergic neurons (Sallinen et al. 2009), suggesting that MAO may 
be responsible for the inactivation of histamine in this species. In nonneuronal 
tissue in mammals, histamine is oxidized by diamine oxidase (DAO, EC 1.4.3.3) 
(Schayer 1953). In contrast to mammals, DAO expression has been observed in 
zebrafish neuronal tissue, specifically in the ventral habenula, which corresponds 
to the mammalian lateral habenula (Amo et al. 2010). Histamine synthesis can be 
inhibited by α-fluoromethylhistidine (α-FMH), which is an irreversible inhibitor of 
HDC (Garbarg et al. 1980). So far, no reuptake system for histamine has been 
identified.  
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Figure 3. Synthesis, storage, release, and catabolism of histamine. ι-Histidine is taken up 
into neurons, where it is converted to histamine by HDC. Histamine is packed into vesicles 
by VMAT2 in the presynaptic terminals, and after release histamine binds to hrh1, hrh2, 
and hrh3 receptors expressed in the brain. In neuronal tissue, histamine is cleared from the 
extracellular space by HNMT and MAO. Histamine is also degraded by DAO (pathway 
indicated in gray).  
Serotonin is derived from ι-tryptophan by two modifications mediated by 
tryptophan hydroxylase (TPH, EC 1.14.16.4) (Lovenberg, Jequier & Sjoerdsma 
1967) and aromatic ι-amino acid decarboxylase (AADC, EC 4.1.1.28) (Lovenberg, 
Weissbach & Udenfriend 1962). Two forms of TPH exist, of which TPH2 is 
expressed in the brain and is responsible for the production of neuronal serotonin 
(Walther et al. 2003). Serotonin is packed into vesicles by VMAT2, transported to 
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the nerve terminals, secreted, and bound to serotonin receptors. Serotonin can be 
taken up into the cells by serotonin reuptake transporters (Torres, Gainetdinov & 
Caron 2003). Inactivation of serotonin is mediated by MAO (Sjoerdsma et al. 1955) 
by formation of 5-hydroxyindoleacetic acid (5-HIAA). The synthesis and catabolism 
of serotonin can be manipulated by different chemicals, such as p-
chlorophenylalanine (PCPA), a selective irreversible inhibitor of TPH (Koe & 
Weissman 1966, Jequier, Lovenberg & Sjoerdsma 1967), ι-deprenyl, which is a 
MAO inhibitor (Fowler, Oreland & Callingham 1981), and fluvoxamine, a selective 
serotonin reuptake inhibitor (Claassen et al. 1977). 
Catecholamines (dopamine, noradrenaline, and adrenaline) are all derived from 
the same amino acid, ι-tyrosine, by the following four enzymatic reactions: 
tyrosine hydroxylase (TH, EC 1.14.16.2) forming ι-dihydroxyphenylalanine (ι-DOPA) 
(Nagatsu, Levitt & Udenfriend 1964), AADC forming dopamine (Lovenberg, 
Weissbach & Udenfriend 1962), dopamine β-hydroxylase (DβH, EC 1.14.17.1) 
forming noradrenaline (Levin, Levenberg & Kaufman 1960) and 
phenylethanolamine Ν-methyl transferase (PNMT, EC 2.1.1.28) forming adrenaline 
(Axelrod 1962). The main enzymes in the degradation of amines are MAO and 
catechol-O-methyl transferase (COMT, EC 2.1.1.6).  
An interesting feature of rodent histaminergic neurons is that they express the 
dopamine-producing enzyme, ι-DOPA (Yanovsky et al. 2011). Furthermore 
histaminergic neurons take up ι-DOPA, the precursor of dopamine, and are 
dopamine-immunoreactive (Yanovsky et al. 2011), suggesting that these neurons 
can also produce dopamine. 
2.1.4 Histaminergic receptor-signaling system  
Aminergic neurotransmission is mediated through G-protein-coupled receptors. 
Histamine acts through the four G-protein-coupled histaminergic receptor 
subtypes 1, 2, 3, and 4 (hrh1, hrh2, hrh3, and hrh4) (Haas & Panula 2003, Haas, 
Sergeeva & Selbach 2008). Of the known receptors, hrh1, hrh2, and hrh3 are 
expressed in the vertebrate brain. hrh4 has also been detected in the mammalian 
brain, but the highest level of hrh4 messenger RNA (mRNA) is found in the spinal 
cord (Strakhova et al. 2009). hrh1 is mainly implicated in regulation of wakefulness 
in rodents (Monti, Pellejero & Jantos 1986, Yanai et al. 1998) and hrh2 is mainly 
involved in cognitive functions in rodents (Dai et al. 2007). hrh3 is expressed in 
mammalian TMN histaminergic neurons and activation of hrh3 reduces the firing 
rate of the neurons and thereby reduces the release of histamine (Arrang, Garbarg 
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& Schwartz 1983, Arrang, Morisset & Gbahou 2007). Furthermore, hrh3 can act as 
a presynaptic heteroreceptor (Schwartz et al. 1990) and regulates the release of 
several other neurotransmitters (Blandina et al. 1996, Yamamoto et al. 1997, 
Schlicker, Werthwein & Zentner 1999, Jang et al. 2001, Pillot et al. 2002b). 
Histamine-mediated neuronal excitation is achieved mainly via activation of hrh1 
and hrh2 receptors in mammals, whereas hrh3 activation inhibits histamine 
release in rats (Arrang, Garbarg & Schwartz 1983). Of the histaminergic receptors, 
the crystalline structure of the human HRH1 together with a first-generation hrh1 
antagonist, doxepin, has been determined (Shimamura et al. 2011), providing 
detailed information on the molecular properties necessary for specific binding of 
ligands to hrh1. The histaminergic receptors signal through different intracellular 
signal transduction pathways (Haas, Sergeeva & Selbach 2008). In Table 1 the 
features of the different histamine receptors are compared. The properties of the 
zebrafish histamine receptor subtypes are not well characterized and require 
further study. 
Table 1. Properties and role of histamine receptors in mammals (modified from Haas, 
Sergeeva & Selbach 2008). For abbreviations in the table, please see list on page 8–9. 
Feature hrh1 hrh2 hrh3 
G protein Gq/11 Gαs Gi/o 
Signal transduction PLC, IP3, DAG, Ca
2+
, 
PKC, AMPK, NF-κB 
AC, cAMP, PKA, CREB AC, cAMP, MAPK, 
Akt/GSK3 
Cellular function Postsynaptic 
excitability  
and plasticity 
Postsynaptic excitability  
and plasticity 
Presynaptic transmitter 
release  
and plasticity 
Systemic function Behavioral  
state and 
reinforcement 
(arousal), 
working memory, 
feeding rhythms, 
energy metabolism, 
endocrine control 
Learning  
and memory 
Blood-brain barrier 
control, behavioral  
state and 
reinforcement 
Pathophysiology Disorders of sleep, 
eating, memory, 
mood, addiction, 
pain and neuro-
inflammation 
Schizophrenia, pain and 
neuro-inflammation 
Disorders of sleep, 
mood, memory, eating, 
addiction, pain and 
neuro-inflammation 
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2.2 Neurotransmitter systems under normal conditions and disease 
2.2.1 Alertness and wakefulness 
Alertness and wakefulness are specific states and important for the survival of the 
individual. Almost a century ago, the Viennese neurologist von Economo noted 
that lesions in the junction between the telencephalon and mesencephalon were 
associated with profound sleepiness in his patients (von Economo 1930). Later, it 
was found that this area harbors the aminergic and peptidergic systems that 
constitute the ascending arousal system (AAS) and activate the cerebral cortex and 
thalamus (Saper, Scammell & Lu 2005). Histamine in the TMN is part of the AAS 
and histaminergic neurons fire during the waking period in mammals (Mochizuki et 
al. 1992, Takahashi, Lin & Sakai 2006). The rest of the components of the AAS 
include the dopaminergic ventral tegmental area, serotonergic raphe nucleus, 
noradrenergic locus coeruleus (Saper, Scammell & Lu 2005), and the 
hypocretin/orexin (hcrt) of the lateral hypothalamus (de Lecea et al. 1998). Hcrt 
signals through two G-protein-coupled receptor subtypes 1 and 2 (hcrt1 and hcrt2) 
in rodents and fish (Trivedi et al. 1998, Panula 2009). Of these two receptors, hcrt2 
is expressed at high densities in mammalian histaminergic neurons (Yamanaka et 
al. 2002). In rodents histamine and hcrt may be responsible for different aspects of 
arousal/wakefulness: histamine mainly responsible for cognitive and motivated 
behaviors and hcrt for motor activity (Anaclet et al. 2009). Reduction in the hcrt 
level causes narcolepsy in humans (Peyron et al. 2000). The symptoms of 
narcolepsy have only been reproduced in hcrt-/- mice, not in hdc-/- mice (Anaclet 
et al. 2009). Serotonin, dopamine, galanin, GABA, thyrotropin-releasing hormone 
(TRH) and methionine-enkephalin (mENK) are also known to affect wakefulness by 
either promotion or inhibition of the AAS (Cirelli 2009). The sleep-promoting 
center in the brain is the ventrolateral preoptic nucleus, which consists of 
GABAergic and galaninergic neurons (Gaus et al. 2002). These neurons innervate 
the nuclei of the AAS (Sherin et al. 1998) and are active during sleep (Szymusiak et 
al. 1998). Together with the AAS clusters, these sleep-promoting neurons regulate 
alertness and wakefulness in mammals.  
Although the above-mentioned neurotransmitter nuclei are located in close 
proximity, not many of the neurotransmitters are colocalized. To better 
understand the role histaminergic neurons play in different behaviors or 
physiological states, the cotransmitters of histaminergic neurons have been 
identified in different species to varying degrees. Histamine is not colocalized with 
serotonin, dopamine, or hcrt in adult zebrafish and the systems have different 
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innervation areas (Kaslin & Panula 2001, Kaslin et al. 2004). Serotonergic fibers and 
dopaminergic fibers mainly innervate the ventral telencephalon, whereas 
histaminergic fibers innervate the dorsal telencephalon (Kaslin & Panula 2001, 
Kaslin et al. 2004). The coexistence of histamine with galanin, GABA, TRH, and 
mENK has been studied in rodents (Airaksinen et al. 1992, Kukko-Lukjanov & 
Panula 2003), but not in zebrafish. In rats, histamine coexist with galanin, TRH, and 
GABA in histaminergic neurons (Airaksinen et al. 1992). In guinea pig, histamine is 
coexpressed with GABA and mENK in histaminergic neurons, whereas in mice 
histamine is colocalized with galanin and GABA in histaminergic neurons 
(Airaksinen et al. 1992). In human TMN, the coexistence of histamine with galanin 
and GABA was studied, and it was found that histamine is colocalized with GABA, 
but not with galanin (Trottier et al. 2002).  
2.2.2 Histamine and neurodegenerative diseases  
Aminergic neurotransmitters have been indicated in several neurological diseases, 
including narcolepsy, AD, PD (Eriksson et al. 2010), and most recently in Tourette’s 
syndrome (Ercan-Sencicek et al. 2010). Narcolepsy is a neurodegenerative disease 
characterized by fragmented sleep and unpredictable sleeping bouts throughout 
the day, and to date there is no cure for this disease (De la Herran-Arita, Guerra-
Crespo & Drucker-Colin 2011). The neurological background is a deficient hcrt 
system in humans (Peyron et al. 2000). The etiology is unknown, although research 
indicates an autoimmune origin (Scammell 2003, Hallmayer et al. 2009, De la 
Herran-Arita, Guerra-Crespo & Drucker-Colin 2011). It is thought that the 
mechanism by which hcrt induces wakefulness is by exciting histaminergic neurons 
via hcrt2 receptors (Bayer et al. 2001). Cataplexy, i.e. loss of muscle tone, is often 
associated with narcolepsy and is usually triggered by emotional excitation (Anic-
Labat et al. 1999). Narcoleptic patients have traditionally been treated with 
stimulants, such as amphetamine (Zaharna, Dimitriu & Guilleminault 2010). Due to 
the addictive potential of amphetamine, a new class of drugs has been designed. 
Modafinil and armodafinil are the best available drugs to treat narcolepsy, 
although the mechanism of action is not known (Zaharna, Dimitriu & Guilleminault 
2010). The European Medicines Agency has approved selective serotonin reuptake 
inhibitors and tricyclic antidepressants for treatment of cataplexy, while the 
American Food and Drug Administration has not (Zaharna, Dimitriu & 
Guilleminault 2010).  
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Narcolepsy has been modeled in zebrafish by disruption of the hcrt system, either 
by hcrt2 receptor null mutation, hcrt2-/-, (Yokogawa et al. 2007) or hcrt 
overexpression (Prober et al. 2006). Both models produce a similar insomnia 
phenotype. In humans affected with sleep disorders, histamine and hcrt 
concentrations are both reduced (Nishino et al. 2009) and patients with 
neurodegenerative disorders display insomnia (Dauvilliers 2007). A comparative 
representation of both neurotransmitter systems and their projections in human 
and zebrafish brain is available in Figure 4. 
 
 
Figure 4. Comparative presentation of hcrt and histamine in the central nervous system of 
humans (left) and zebrafish (right). The histaminergic and hcrt neurotransmitter systems 
are conserved between the two species. The fibers from each neurotransmitter system 
innervate the neurons of the other in both humans and zebrafish. The projection pattern of 
the neurons is similar in these species, since the fibers innervate the majority of the brain 
regions. Please note that the brains are not depicted in correct scale in regard to each 
other. 
AD is the most common neurodegenerative disease worldwide, with cognitive 
decline and dementia as the main manifestations. The neurological hallmarks 
include reduced brain size, neurofibrillary tangles, and amyloid plaques (Bishop, Lu 
& Yankner 2010). The majority of AD cases are sporadic (Blennow, de Leon & 
Zetterberg 2006) and affects persons older than 65 years. The early-onset familial 
form of AD has an onset around 30 years (Blennow, de Leon & Zetterberg 2006). 
The familial forms of AD are due to mutations in the following genes: amyloid 
precursor protein (app), presenilin1 (psen1) and presenilin2 (psen2). Both PSEN1 
and PSEN2 are part of the γ-secretase complex (Kimberly et al. 2003), which is 
expressed within the membranes of the neurons, including the cell membrane, 
endoplasmic reticulum, Golgi apparatus, and mitochondria (Kovacs et al. 1996, Xu 
et al. 2002, Hansson et al. 2004) (Figure 5). The cognitive decline associated with 
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AD is mainly due to reduced acetylcholine levels in the brain, which results from 
reduced numbers of neurons and neuronal dysfunction (Whitehouse et al. 1982). 
 
 
Figure 5. The γ-secretase complex is composed of four proteins, PSEN1 or PSEN2, 
presenilin enhancer 2 (PEN-2), nicastrin and anterior pharynx-defective 1 (APH-1), and 
resides in the membranous organelles of the cell and the cell membrane. These proteins 
are not depicted in the correct relation to each other in the figure. 
The γ-secretase complex is thought to have many functions, including cleavage of 
APP (Borchelt et al. 1996), regulation of the calcium (Ca2+) homeostasis (Guo et al. 
1996, Stutzmann et al. 2004), cleavage of the Notch receptor (Levitan & Greenwald 
1995), and involvement in Wnt/β-catenin signaling (Serban et al. 2005). Notch 
signaling is important in embryonic neural development and in the adult brain 
(Ables et al. 2011). In zebrafish, inhibition of γ-secretase with DAPT (N-[(3,5-
Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine-1,1-dimethylethylester) affects 
Notch signaling (Geling et al. 2002). PSEN1 functions also independently of the γ-
secretase complex. The regulation of Wnt/β-catenin signaling is an example of this 
(De Strooper & Annaert 2010). In this case, PSEN1 is important for degradation of 
β-catenin (Kang et al. 2002) and lack of PSEN1 is associated with an increase in β-
catenin signaling (Xia et al. 2001). Wnt/β-catenin signaling, as is Notch signaling, is 
an important signaling cascade during embryonic development, but also plays a 
role in the adult CNS (Inestrosa & Arenas 2010) and in the progression of AD 
(Boonen, van Tijn & Zivkovic 2009). 
Interestingly, amyloid formation is regulated by hcrt and the sleep-wake cycle, 
indicating that there may be a correlation between the AAS and pathogenesis of 
AD (Kang et al. 2009). Kang et al. (2009) showed that lack of hcrt would protect 
against AD, but a study on the coexistence of narcolepsy with AD found that also 
narcoleptics are affected by AD (Scammell et al. 2011). In postmortem brains of AD 
patients, the histamine content is reduced (Panula et al. 1998, Shan et al. 2012). 
The underlying mechanism for this alteration in histamine content is not known. 
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One possible mechanism may be associated with hypoxia, since human HDC 
expression is regulated by hypoxia-inducible factor 1 (Jeong et al. 2009) and 
hypoxia in general is associated with the progression of neurodegenerative 
disorders, such as AD (Zlokovic 2011). So far, it is not known if neuronal HDC can 
be induced by hypoxia. Furthermore, histaminergic neurons exert neuroprotective 
effects in organotypic slice preparations during excitotoxic insults (Kukko-Lukjanov 
et al. 2006). Other possible mechanisms include alteration in neurogenesis and/or 
proliferation during development (Wen et al. 2002, Chevallier et al. 2005, 
Rodriguez, Jones & Verkhratsky 2009) or activity-dependent neurotransmitter 
specification (Spitzer 2012), that later on in adulthood may affect the balance of 
neurotransmitter systems in normal and diseased brains. Histamine receptor 
expression has been examined in the prefrontal cortex of AD patients. In human 
brain samples, hrh1 binding was decreased (Higuchi et al. 2000), hrh2 mRNA was 
unaltered (Perry et al. 1998, Shan et al. 2012), and hrh3 mRNA was increased (Shan 
et al. 2012). The increase in hrh3 mRNA was only observed in female AD patients 
(Shan et al. 2012). Taken together, understanding of the mechanisms that underlie 
altered histaminergic neurotransmission will provide further insight into AD 
progress. There is no cure for AD currently, and treatments can only ease the 
symptoms of the disease. Acetylcholinesterase inhibitors and N-methyl-D-aspartic 
acid antagonists (Wollen 2010) are widely used treatments. Stimulatory therapies, 
which include physical exercise, socialization, cognitive training, and music, are 
emerging as new therapeutics (Wollen 2010). Since the life expectancy of our 
population is increasing, new therapies, but especially better understanding of the 
etiology of the disease, are needed to combat the progression of AD. In zebrafish, 
the role of psen1 has been studied by transiently inhibiting gene expression. 
Transient knockdown of psen1 in zebrafish (Nornes et al. 2003, 2008, 2009) 
phenocopies the features reported for the psen1 knockout mice (Shen et al. 1997), 
i.e. disrupted CNS formation and Notch signaling. 
2.3 Zebrafish as a vertebrate model organism 
The zebrafish belongs to the bony fishes (Teleosts) of the ray-finned fishes 
(Actinopterygii), which comprise the majority of all living fish. The actinopterygian 
fishes and mammals shared an ancestor about 500 million years ago (Metscher & 
Ahlberg 1999, Grillner & Jessell 2009). The zebrafish is a vertebrate model 
organism that was initially used in developmental biology studies during the 1970s. 
During the last decade, the popularity of this vertebrate model has grown in the 
field of neuroscience (Panula et al. 2006, 2010, Sager, Bai & Burton 2010). The 
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main advantages, such as its small size (approximately 4 cm in length) and 
transparent ex utero development in combination with feasibilities of genetic 
manipulation, have rendered it a good model for studying neuronal circuits 
underlying behavior. Importantly, the neuroanatomy of zebrafish correlates well 
with that of other vertebrates studied, which is one of the reasons it can be 
utilized as a model for studying the mechanisms underlying human disease. In 
addition, tracing and lesion studies have also been undertaken to elucidate the 
neuroanatomy and the role of different brain areas in fish and how these can be 
correlated with other vertebrates. The similarity in organization of various 
neurotransmitter systems among several vertebrate species has further motivated 
the use of zebrafish as a model in neuroscience. Due to the small size of the 
zebrafish, 3D imaging of whole neurotransmitter systems is possible. These 
methods, combined with targeted stimulation or ablation of single neurons, render 
the zebrafish a powerful tool for studying the role of specific neurons (Burgess & 
Granato 2007b). For example, Ca2+ imaging can be used to correlate the activity of 
a neuron with specific stimuli (O'Malley, Kao & Fetcho 1996, Orger et al. 2008). 
Other possible tools that are currently available include optogenetics, which allows 
noninvasive activation of neurons within millisecond ranges (Szobota et al. 2007, 
Douglass et al. 2008), and high-throughput pharmacological experiments 
combined with a behavioral assay (Rihel et al. 2010). The availability of a large 
number of transgenic and mutant fish lines combined with the above-mentioned 
appealing approaches for studying behavior makes this an excellent model 
organism for use in neuroscience.  
2.3.1 Comparative neuroanatomy of fish and mammals  
The telencephalon develops in actinopterygian fishes via eversion, whereas in 
other vertebrates it develops via evagination. The difference in development was 
postulated to be the reason for the nonlaminar telencephalon in actinopterygian 
fishes (Ito & Yamamoto 2009). In actinopterygian fishes, the telencephalon can be 
grossly divided into the dorsal telencephalon, i.e. the pallium, and the ventral 
telencephalon, i.e. the subpallium (Nieuwenhuys 1963, 2010, Nieuwenhuys, ten 
Donkelar & Nicholson 1998) (Figure 6). Based on tracing and gene expression 
studies the basal ganglia, including the striatum, was suggested to be located in 
the ventral telencephalon (Rink & Wullimann 2001, Mueller, Wullimann & Guo 
2008, Ganz et al. 2011). Toxicity studies, neuronal connectivity, and tracing studies 
have suggested that the teleost correlate to the mammalian substantia nigra, 
which is part of the basal ganglia, is located in the diencephalon of larval zebrafish 
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(Kaslin & Panula 2001, Rink & Wullimann 2004, Sallinen et al. 2009). The dorsal 
part of the dorsal telencephalon (Dd, Figure 6) in goldfish may correspond to the 
mammalian cerebral cortex (Vargas, Lopez & Portavella 2009). Recent results 
indicate that the Dd region does not exist in zebrafish and that the central part of 
the dorsal telencephalon (Dc) corresponds to the mammalian cortex (Mueller et al. 
2011). Based on lesion studies of the medial pallium, the area corresponding to the 
mammalian amygdala may be located in the medial region of the dorsal 
telencephalon (Dm, Figure 6) in goldfish (Portavella et al. 2002, Portavella & Vargas 
2005). Similar lesion studies of the lateral pallium suggest that the phylogenetically 
conserved area that corresponds to the mammalian hippocampus in goldfish is in 
the lateral region of the dorsal telencephalon (Dl, Figure 6) (Portavella, Torres & 
Salas 2004, Portavella & Vargas 2005). The dorsal telencephalon is highly 
innervated by histaminergic fibers (Kaslin & Panula 2001). In contrast, 
dopaminergic, serotonergic, and hcrt fibers innervate the ventral telencephalon 
(Kaslin & Panula 2001, Kaslin et al. 2004).  
 
Figure 6. Comparative analysis of the telencephalic areas in fish (left) and mammals (right). 
Dd = dorsal area of dorsal telencephalon, Dm = medial area of dorsal telencephalon, Dl = 
lateral area of dorsal telencephalon, Dc = central area of dorsal telencephalon, Dp = 
posterior area of dorsal telencephalon. In zebrafish, the area that is suggested to 
correspond to the mammalian cortex is Dc, whereas studies in goldfish proposed Dd. 
The thalamic complex in mammals is a major structure of the diencephalon and 
consists of three regions: prethalamus, zona limitans intrathalamica, and thalamus. 
The development of the thalamus is evolutionarily conserved, as suggested by a 
comparative analysis of mouse, chicken, and zebrafish. The study demonstrated 
that homologous genes are responsible for development of the thalamic nuclei in 
these three different species (Scholpp & Lumsden 2010).  
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The hypothalamus is located below the thalamus and is connected to the pituitary 
(Nieuwenhuys, ten Donkelar & Nicholson 1998). By release of neuropeptides and 
neurotransmitters, the hypothalamus maintains the homeostasis of the organism 
and is involved in endocrine and metabolic control of body functions and 
behaviors. For example, arousal is tightly regulated by the nuclei in the 
hypothalamus (Scammell 2003). The mammalian and zebrafish hypothalamus are 
not anatomically very alike, but the equivalents of the neuronal nuclei that are 
found in the mammalian hypothalamus are also found in zebrafish (Machluf, 
Gutnick & Levkowitz 2011). The ventrocaudal hypothalamus is the site of the 
histaminergic neurons, and some of the serotonergic, dopaminergic, and hcrt 
neuron populations are also located in this region in zebrafish (Kaslin & Panula 
2001, Kaslin et al. 2004). To evaluate the role of the cerebellum in modulation of 
motor behaviors, the cerebellar anatomy has been described and mutations that 
affect the development of the cerebellum have been produced (Bae et al. 2009). 
2.3.2 Zebrafish behavior and motor functions 
At as early as 17 hours postfertilization (hpf), zebrafish larvae show spontaneous 
movement (Brustein et al. 2003). The activity of the fish increases during the 
course of a few days and at 4–5 dpf, a mature beat-and-glide swimming pattern 
can already be observed. At this age, the larvae begin to hunt for food, since the 
nutrients of the yolk sac have been almost completely consumed. Fundamental 
behaviors, such as prey capture (Budick & O'Malley 2000) and sleep (Prober et al. 
2006, Zhdanova 2006), can be assessed in zebrafish larvae. 
The neuronal circuits in the spinal cord and brainstem that underlie behavior have 
been studied in zebrafish (discussed below). In contrast, the involvement of the 
telencephalon in execution of behaviors has not been assessed (Figure 1). To date, 
there are no identified neuronal circuits that connect the telencephalon with the 
brainstem (Figure 1). The optic tectum of zebrafish corresponds to the superior 
colliculus of mammals and in both cases the main task is to integrate visual 
information with motor output (Isa 2002, Sato et al. 2007, Del Bene et al. 2010). 
The brainstem nuclei regulate the lower motor neurons and mediate modulatory 
inputs from the telencephalon and cerebellum. The spinal cord harbors the motor 
and sensory connections and it is this area that coordinates several reflexes. 
To link specific neurons with neuronal networks and to identify the circuits 
underlying behavior, specific behaviors can be dissected into smaller units. This 
allows the identification of which movement patterns zebrafish larvae combine to 
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produce specific behaviors. Dependent on the behavior studied, movement 
patterns can be identified by different methods. Identification of the movement 
patterns zebrafish combine to produce behavior, such as prey capture or startle 
response, requires high-frequency imaging (500–1000 frames per second). Others, 
such as sleep, place preference, and general activity, can be assessed with low-
frequency imaging (5 frames per second or less). Different stimuli elicit distinct 
responses in zebrafish larvae. Acoustic/vibrational stimuli induce a rapid escape 
response (Burgess & Granato 2007b), whereas dark flashes induces a slower 
response (Burgess & Granato 2007a). For navigational purposes, adjustment 
moves such as turns and scoots (Burgess, Schoch & Granato 2010) and slow-
swimming with the pectoral fins can be detected (Budick & O'Malley 2000).  
The reticulospinal neurons in the brainstem of larval zebrafish project to the spinal 
cord to regulate execution of many behaviors. The Mauthner neuron (Figure 7) is 
the best known and is thought to be the sole driver of the escape response, which 
is also called the startle response. The startle response of freely moving larval 
zebrafish can be divided into short-latency and long-latency startle responses 
(Burgess & Granato 2007b). Both types of startle responses last for several 
milliseconds and are completed in less than 1 second after stimulation. The short-
latency startle response is mediated by the Mauthner neuron, whereas the long-
latency startle response is not (Burgess & Granato 2007b). Other neurons of the 
brainstem, such as MID2cm (Mauthner neuron homologue, middle dorsal 2 
contralateral medial longitudinal fasciculus interneuron in rhombomere 5) and 
MID3cm (Mauthner neuron homologue, middle dorsal 3 contralateral medial 
longitudinal fasciculus interneuron in rhombomere 6) cooperate with the 
Mauthner neuron in giving the escape/startle response a direction (Figure 7) 
(O'Malley, Kao & Fetcho 1996). Stimulation of the head causes both the Mauthner 
neuron and MID2cm or MID3cm neuron to respond, whereas when the tail is 
stimulated, only the Mauthner neuron is activated (O'Malley, Kao & Fetcho 1996). 
Among the medial longitudinal fasciculus (nMLF) neurons active during forward 
swimming have been identified (Orger et al. 2008). In the same study, neurons that 
execute right or left movements were also identified. A schematic drawing of the 
anatomical position of the neurons described is presented in Figure 7 and their 
connections via commisural interneurons to the lower motor neurons in the spinal 
cord are also illustrated.  
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Figure 7. Lateral view of a zebrafish brain. The main brain areas are indicated and the 
nMLF, Mauthner neuron, MID2cm, MID3cm, and the relationship to the histaminergic 
neurons and their projections are illustrated. Furthermore, the interaction of the lower 
motor neurons with the interneurons is visualized.  
In both larval and adult zebrafish, the response to changes in the environment can 
be assessed. This can either be studied by moving white and black stripes 
unidirectionally under the freely moving fish, which causes an optomotor 
response, or by fixing the animals and monitoring their eye movements, which in 
turn causes an optokinetic response. These two assays have successfully been used 
to screen for visual system defects in mutants (Brockerhoff et al. 1995, Muto et al. 
2005). Changes in illumination mediate a Mauthner neuron-independent 
behavioral response that has been classified as an О-bend, which may be strictly 
navigational (Burgess & Granato 2007a, Burgess, Schoch & Granato 2010). In this 
study, we assessed a similar response, i.e. an increase in locomotor activity when 
zebrafish larvae are exposed to sudden changes in illumination. We call this 
response a dark-induced flash response. 
2.3.3 Behavioral pharmacology 
Pharmacological experiments are easily performed in zebrafish larvae, since they 
can be immersed in drugs. High-throughput screening of thousands of molecules 
combined with a behavioral readout has been successfully developed to study 
sleep-wake regulation in zebrafish larvae (Rihel et al. 2010). Depending on the 
properties of the drug, an appropriate solvent must be used to ease the uptake of 
the drug into the larvae. Furthermore, the blood-brain barrier in zebrafish begins 
to develop at 3 dpf (Xie et al. 2010), but is not fully functional until 9 dpf (Jeong et 
al. 2008). The timeline for the development and maturation of the blood-brain 
barrier therefore offers a window when drugs are easily taken up into the brain. 
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2.3.4 Modification of gene expression with morpholino oligonucleotides 
To transiently inhibit gene expression, morpholino oligonucleotides (MOs) have 
been developed. The MOs can be designed to inhibit gene expression via two 
different approaches: 1) by inhibiting the binding of the ribosomal subunits to the 
mRNA initiation site by targeting the MO upstream of the initiation site or 2) by 
interfering with the splicing of the premature mRNA by targeting the MO to the 
exon-intron or vice versa boundary. The MOs are injected into zebrafish embryos 
at the 1–4-cell stage. Since the effect of the MO is only transient and usually ceases 
within the first week of life, the effect of transient downregulation can only be 
assessed in larval zebrafish. Care must be taken that the expression of the gene of 
interest is downregulated throughout the observation time. This can be done by 
verifying loss of the protein by immunohistochemistry (IHC) or Western blotting. If 
a splice site MO is used, then the expression of mature mRNA can be assessed by 
real-time polymerase chain reaction (RT-PCR). MOs quite often also induce off-
target effects, such as edema and increased cell death (Robu et al. 2007, Eisen & 
Smith 2008). Different approaches to control the specificity of the MO have 
therefore been proposed. For example, several MOs could be used to induce the 
same phenotype and activation of the p53 pathway could be assessed by 
quantitative real-time polymerase chain reaction (qPCR) or by coinjecting MO the 
that targets the p53 pathway, and rescue of the phenotype is recommended by 
injection of target gene mRNA. There are some problems with these approaches, 
since some target genes may indeed be involved in the upregulation of cell death 
pathways (Sallinen et al. 2010). 
2.3.5 Modification of gene expression by inducing mutations into the genome 
Chemical mutagenesis was applied to zebrafish almost two decades ago (Driever et 
al. 1996) and this approach required forward genetics to identify the mutation-
carrying gene. To speed up the process, the TILLING (Targeting induced localized 
lesions in genomes) tool was developed. TILLING is a reverse genetic approach by 
which knockout animals can be obtained. TILLING was initially set up for 
Arabidopsis thaliana (McCallum et al. 2000, Colbert et al. 2001) and later modified 
to allow target-selected mutagenesis in zebrafish (Wienholds et al. 2002, 2003). 
Random gain-of-function or loss-of-function mutations are induced into genomes 
by treating male zebrafish with a highly potent mutagen, N-ethyl-N-nitrosourea 
(ENU, chemical formula C3H7N3O2), which targets the spermatogonial stem cells 
(Driever et al. 1996). After a recovery period the ENU-treated males are mated 
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with healthy wild-type (WT) female zebrafish to produce an F1 offspring 
generation. Genomic DNA is prepared from fin clips of this live library or from 
sperm kept in a frozen library, and the individuals are screened for mutations in a 
specific gene. The plant endonuclease CEL-I can be used for detection of the 
mutations, since it detects all of the currently known sequence variants, including 
deletions, insertions, and missense alterations (Oleykowski et al. 1998). Since ENU 
is a highly potent mutagen that induces random mutations throughout the 
genome, it is advisable to outcross identified carriers for several generations to 
reduce the number of background mutations.  
Designed targeted mutagenesis is possible via the zinc finger nuclease (ZFN) and 
TALEN (Transcription activator-like effector nuclease) methods (Caroll, Zhang 
2011). These two methods have higher specificity for the genomic target sequence 
and thereby produce fewer off-target effects (Doyon et al. 2008, Meng et al. 2008) 
than random mutagenesis induced with ENU. ZFN and TALEN function in a similar 
manner. They are heterodimers that consist of a catalytic unit (FokI endonuclease) 
that introduces double-stranded breaks at specific genomic sites, and a targeting 
unit that is a DNA-binding unit consisting of several DNA-binding modules. The 
double-stranded breaks are then repaired by the DNA repair machinery, which 
introduces small insertions or deletions that can cause frameshift knockout 
mutations (Bibikova et al. 2003). The difference between ZFN and TALEN is that 
each ZFN DNA-binding module recognizes three nucleotides, whereas the TALEN 
DNA-binding module recognizes only one, resulting in higher specificity (Caroll & 
Zhang 2011). The ZFN method has been available for a decade (Smith et al. 2000), 
but due to the high uncertainty with the ZFN design, it has not been used 
extensively in zebrafish research. Due to the favorable aspects and increased 
knowledge of the methods, the ZFN and TALEN methods will most likely also 
become more commonly used in zebrafish research.    
2.3.6 Spatially and temporally targeted gene expression 
Methods for targeted gene expression in desired tissues have also been described. 
The medaka (Oryzias latipes) Tol2 transposon system in combination with the 
Gal4/UAS (upstream activating sequence) system has been used to express genes 
downstream of the UAS in specific neurons (Halpern et al. 2008, Asakawa & 
Kawakami 2009, Suster et al. 2009). In this manner, the neural circuits underlying 
the touch response in zebrafish were unraveled. Inhibition of neurotransmitter 
release from Gal4-positive hindbrain interneurons and Rohon-Beard sensory 
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neurons by expression of tetanus toxin (TeTx) under the UAS resulted in lack of a 
touch response (Asakawa et al. 2008, Asakawa & Kawakami 2009). This method for 
spatially targeted gene expression can also be further modified to express genes in 
a temporal manner (Halpern et al. 2008). This method requires, as does TILLING, 
large facilities for housing and screening the different Gal4 fish lines that later on 
are crossed with UAS fish.  
2.3.7 Appropriateness of modeling human disease in a simple vertebrate 
The molecular pathways underlying many disorders in humans are still unknown 
and new inexpensive models are needed to contribute in the quest to reveal these 
mechanisms. Invertebrates such as Caenorhabditis elegans and Drosophila 
melanogaster have already provided insight into some of the mechanisms 
underlying human disease processes. The zebrafish was initially used as a model 
organism in developmental studies but has during the past decade become more 
widely used to model various human diseases, ranging from disorders of the 
nervous system, e.g. attention deficit hyperactivity disorder (Lange et al. 2012), to 
leukemia (Ridges et al. 2012). The zebrafish is, due to its small size, less expensive 
to keep in large quantities than are rodents. In addition, zebrafish may by the 
public be considered as a more ethical choice than mammals as disease models. 
The major drawback of zebrafish in modeling human disease is that it has 
undergone the genome duplication event, and therefore some of the genes in the 
zebrafish are duplicated, whereas in other cases one gene in zebrafish carries the 
properties of both human homologues. An example of this is the enzyme 
responsible for converting ι-tyrosine to ι-DOPA, TH, which in zebrafish is duplicated 
(Chen, Priyadarshini & Panula 2009). So far, the function of zebrafish TH2 is 
unknown and zebrafish TH1 converts ι-tyrosine to ι-DOPA, just as in humans. 
Another example is MAO in zebrafish, which carries features of both human MAO-
A and MAO-B (Anichtchik et al. 2006). Naturally, the novel insights obtained in 
zebrafish must be studied in mammalian model organisms and humans before 
conclusions regarding the findings are applicable to humans and human disease. 
Taken together, the above-mentioned results indicate that the zebrafish is an 
appropriate tool for modeling human disease to answer mechanistic questions.  
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3 Aims of the study 
The main goal of this thesis project was to study the functions of neuronal 
histamine; the interactions of the system with other neurotransmitter systems, its 
role in neuronal plasticity, and the neuronal circuits underlying behavior. The 
zebrafish was chosen as a model organism and various methods for quantifying 
larval zebrafish behavior were established.  
The specific aims of the thesis were the following: 
I Identify and characterize the histamine receptors in zebrafish and 
the behavioral effects of their ligands, 
II Identify the cotransmitters of the histaminergic neurons, 
III  Study the role of histamine in alertness and wakefulness, 
IV Elucidate the factors that regulate the development of histamine 
neurons by characterizing the system in psen1 knockout fish, and 
V Assess the role of MAO in behaviors driven by amines. 
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4 Methods 
Please find more detailed information regarding the materials and methods in the 
original publications. 
4.1 Animals 
Several zebrafish strains were used in this thesis. For the studies in I–III and V, a 
WT strain that originated from Abo Akademi University and which was used in the 
following studies (Kaslin & Panula 2001, Peitsaro et al. 2003, Kaslin et al. 2004, 
Sallinen et al. 2009, 2010) was used. For the results in unpublished form (IV), a 
homozygote TILLING mutant line carrying a premature stop codon in the psen1 
gene (hu2547) was used. This line was a kind gift from Dr. Zivkovic (Hubrecht 
Institute of Developmental Biology and Stem Cell Research, Royal Netherlands 
Academy of Arts and Sciences, Amsterdam, and University Medical Center, 
Utrecht, The Netherlands). The mutation was induced in the Tubingen longfin (TL) 
strain and we therefore used the TL strain as the control WT line in studies with 
the mutant. Fish handling and housing (+26–28 °C, 14:10 light-dark cycle) were 
done as previously described (Westerfield 2007). The permits for the experiments 
were obtained from the Animal Experiment Board of the Regional State 
Administrative Agency for Southern Finland, in agreement with the ethical 
guidelines of the European Convention. 
4.2 Manipulation of gene expression by morpholino oligonucleotides (III) 
We designed an MO that targeted the initiation site of the hdc mRNA (atg), 5’-
CATCCCGTCACTCAGAGAAGATTAG-3’. A standard (std) control MO was used as the 
control (both MOs from Gene Tools). At 5–6 hpf, the success rate of the injection 
was observed in a fluorescence microscope, since the MOs were tagged with 
fluorescein. Any uninjected embryos within the MO-injected groups were excluded 
from the experiment. The injected embryos were grown until 5 dpf or older, when 
the experiments were conducted. Uninjected WT animals were used as additional 
controls. 
4.3 Pharmacological treatments  
For the pharmacological studies, zebrafish larvae were dechorionated with forceps 
at 24 hpf and raised in 6-well plates with 3 ml of embryo medium (E3: 5 mM NaCl, 
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0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, all reagents from Sigma-Aldrich) to 
which the drug was added. The group size varied between n=10–35. If the drug 
treatment was started at 5 dpf or later, the fish were raised in petri dishes until the 
appropriate age. The E3 medium with the drug was usually changed once daily. 
4.3.1 Treatment with histamine receptor ligands or α-fluoromethylhistidine (III) 
Zebrafish larvae were treated with 1, 10, or 100 μM pyrilamine (Sigma-Aldrich), 
cimetidine (Sigma-Aldrich), thioperamide or immepip. The thioperamide and 
immepip were kind gifts from Professors Rob Leurs and Henk Timmerman (Vrije 
Universiteit, Amsterdam, The Netherlands). The control groups were kept in E3 
medium. The treatments were initiated at 2–3 hpf, 1 dpf, or 2 h before the 
behavior was assessed. The locomotor activity was observed at 5 dpf. The α-FMH 
was a kind gift from Dr. Kollonitch (Merck) and the treatments were 1 mM for 1–5 
or 1–7 dpf before behavior (please see 4.4) or hcrt whole-mount in situ 
hybridization (WISH, please see 4.9). 
4.3.2 Deprenyl, p-chlorophenylalanine, and fluvoxamine treatments (V) 
Fish exposed to solutions containing deprenyl (Sigma-Aldrich) at 1, 10, or 100 μM 
were further divided into three groups. The fish were exposed to the drug for 
different times, either 0–7 dpf, 0–5 dpf or only 2 h preceding testing. For deprenyl 
and PCPA (Sigma-Aldrich) treatment, the fish were divided into six groups and 
exposed to 150 μM or 1.5 mM PCPA for 1–5 dpf and/or 100 μM deprenyl 0–5 dpf. 
The fluvoxamine (Sigma-Aldrich) treatments were also done in combination with 
deprenyl (100 μM 0–5 dpf) or alone by exposing zebrafish to 100 μM fluvoxamine 
2 h before the animals were killed at 5 dpf. The control groups received no drugs. 
4.3.3 γ-Secretase inhibitor DAPT treatments (IV) 
The DAPT in solution (Tocris Bioscience) was diluted in dimethyl sulfoxide (DMSO) 
to reach a final concentration of 2.5 mM. At 1 dpf, 30 fish per treatment group 
were dechorionated, moved to 6-well plates, and kept in 3 ml of E3 medium 
containing either 1% DMSO or DAPT. After the treatment, the fish were killed and 
fixed with 4% 1-ethyl-3,3(dimethyl-aminopropyl) carbodiimide (EDAC; CMS 
Chemicals) diluted in 0.1 M phosphate buffer, pH 7.0. 
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4.4 Behavioral tests 
To assess the effect of histamine on behavior, several behavioral assays were 
developed during the course of this thesis. The behavioral experiments were done 
during the light period of the day, unless otherwise mentioned. The zeitberger 
time (ZT) onset was at 9.00 in the morning (ZT0) and lights went off at 23.00 in the 
evening (ZT14). The behavioral data were either collected by i) observing the fish 
and manually scoring the specific behaviors or ii) a video camera and further 
analyzed with EthoVision 3.1 software (Noldus Information Technology). Advanced 
calibration of the arenas was applied in each case when the EthoVision software 
was used. All behavioral experiments were done at room temperature (RT) and 
repeated three times with different fish. 
4.4.1 Locomotor activity of zebrafish (I, III–V) 
The larvae were placed in individual hemisphere-shaped chambers (diameter 4 cm, 
volume 12 ml) or in the wells of a 48-well plate (volume 1 ml) and analyzed for 10 
min at a sample rate of 5–25 frames per second. The total distance moved (cm), 
turn angle (degrees), and movement (percentage of time fish spent moving) were 
calculated from the coordinates acquired, using the EthoVision software. System 
noise was removed, using an input filter of 0.2 cm for minimum distance moved. 
The tracks were excluded if the sample size (i.e. the number of frames in which the 
animal was detected) did not exceed 90% of the maximum sample size or if 
reflections were detected. The locomotor activity (total distance moved, cm) of 
adult zebrafish was analyzed in the same manner as for the larvae, with the only 
difference being that the arenas used were larger (diameter 22 cm, volume 2 l). 
4.4.2 Place preference (IV) 
Place preference was assessed in the same arenas as the locomotor activity. The 
arenas were divided into several zones (in EthoVision) and the time the fish spent 
in each zone during the tracking period was determined. 
4.4.3 Place preference in a water column (V) 
A vertical place preference test was done in a 2-ml cylinder filled with E3 medium. 
Two groups were used: a control group without drug treatment and a ι-deprenyl 
group with treatment of 100 μM ι-deprenyl for 0–5 days. Ten 5-day-old larvae 
were placed in a cylinder and allowed to accommodate for 5 min. The cylinder was 
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divided into upper and lower parts. The number of fish in the lower part was 
counted every 5 min for 25 min.  
4.4.4 Locomotor activity of larval zebrafish over a 24-h period (III) 
The activity and frequency of movement were observed during a 24-h period. The 
zebrafish larvae (5 dpf) were placed individually in the wells of white 96-well plates 
5 hours before tracking, which was started at ZT14. A video camera connected to a 
computer with EthoVision software was used for tracking the fish illuminated by 
infrared lights. Two parameters were analyzed: frequency of movement and total 
distance moved per hour.  
4.4.5 Dark-induced flash responses in larval zebrafish (III, IV) 
In this behavioral test, we studied whether light per se affects the activity of fish. 
We set up an assay to approach this, which was similar to assays in previous 
studies in which related behaviors were assessed (Burgess & Granato 2007a, 
Burgess & Granato 2007b, Emran, Rihel & Dowling 2008). Light-induced decrease 
in locomotor activity and dark-induced flash response of morphant fish were 
assessed by observing 5 dpf fish during 2 min periods of lights on and off for 10 
min. The fish were transferred to 48-well plates on the day of observation, 
illuminated by infrared lights, and their movement was recorded with the same 
system as described above. 
4.4.6 Optomotor response (III) 
An optomotor response assay was developed for the initial zebrafish mutation 
screen to identify visual system defects in mutants. We used a simplified version of 
the optomotor assay by manually moving a paper with black and white stripes (1-
cm-wide stripes) for 30 seconds under a plate with 6–7 dpf zebrafish larvae and 
observing whether or not the larvae adjusted their direction of swimming in the 
direction of movement of the stripes. 
4.5 Lipophilic dye DiI tracing (III) 
Micropipettes were filled with 20% carbocyanine dye DiI (Molecular 
Probes/Invitrogen Corporation) solution (diluted in 1:1 ethanol:DMSO). After 
anesthetization of the fish, the needle was placed perpendicularly to the body axis 
and 2 nl of the tracer was injected, by PV830 Pneumatic PicoPump (World 
Precision Instruments Inc.) at a pressure of 30 psi for 5 ms, through the skin to the 
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superficial part of the right dorsal telencephalon of 9 dpf larvae. The injection was 
done under a stereomicroscope and targeting was verified immediately with a 
Leica MZFBL III fluorescence microscope (Leica Microsystems GmbH). After the 
injection, the larvae were kept alive 1 h, killed and fixed with ice-cold 4% EDAC. 
4.6 Real-time polymerase chain reaction 
4.6.1 Cloning of zebrafish hrh1, hrh2, and hrh3 receptors in adult zebrafish (I) 
Sanger Institute zebrafish blast pages (http://www.ensembl.org/Danio_rerio) were 
used to identify sequences that are similar to the human hrh1, hrh2, and hrh3 
receptors. The coding sequences predicted for the receptors were amplified, using 
PCR. RNA isolated from adult zebrafish brains was used as a template for the 
reactions. The RNA was extracted with RNAwiz™ (Ambion Inc.) and 
complementary DNA (cDNA) was reverse-transcribed, by the First-Strand Synthesis 
Kit (Amersham Biosciences) or by the SuperScript™ First-Strand Synthesis System 
(Invitrogen Corporation) according to the manufacturers’ instructions. The 
following primers were used: hrh1 (DQ647806) forward 5′-
TGTCTCTCCTCACCGTCATC-3′ and reverse 5′-CAATCCCTTCATTTACCCGCTCT-3′; hrh2 
(DQ647808) forward 5′-ATGCAATTTATATTCAGCGAT-3′ and reverse 5′-
ACTACCTTTTACTCCCATTAGC-3′; hrh3 (DQ647807) forward 5′-
ATGGAGAGAGAAAACGCG-3′ and reverse 5′-AATACTTCTGGTCAATGTTC-3′. The 
amplified PCR products were sequenced from both directions (PRISM 310; Applied 
Biosystems Inc.). 
4.6.2 Expression of hrh1, hrh2, and hrh3 mRNA (I) 
RNA was extracted from fish at different developmental stages (3, 6, 11, 24, 48, 
and 72 hpf, 5, 7, and 10 dpf) from freshly isolated brains, eyes, gills, intestine, 
heart, liver, muscle, and spleen from 10 adult fish and reverse-transcribed as 
described above. cDNA originating from 0.25 μg total RNA was used for the PCR 
reactions, which were carried out with the same primer pairs as above for hrh1, 
hrh2, and hrh3. 
4.6.3 Cloning full-length hdc cDNA and synthesis of capped hdc mRNA (III) 
The 5' half of zebrafish hdc cDNA was amplified with primers, forward 5’-
ATGCAGCCGCAGGAGTACAT-3’ and reverse 5’-GGCTGCCGGGTCACGACT-3’, with 
the partial hdc clone (Yokogawa et al. 2007) as PCR template. The 3' half was 
amplified with forward 5’-GTCCTGAGCTGCGCTATTTC-3’ and reverse 5’-
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GTTATTTAGTAGGCAGCGGTGTG-3’ primers by RT-PCR from total RNA extracted 
from adult zebrafish hypothalamus. The full-length hdc cDNA was acquired by 
splice overlap extension (SOE) PCR, with forward 5’-ATGCAGCCGCAGGAGTACAT-3’ 
and reverse 5’-GTTATTTAGTAGGCAGCGGTGTG-3’ primers. All the above-
mentioned PCR reactions were done with Phusion high-fidelity DNA polymerase 
(Finnzymes), which makes blunt end PCR products. The 3’ end of the full-length 
fragment acquired was modified to increase the stability of the fragment with an 
adenosine-tailing procedure that adds 3´ adenosine overhangs. This modification 
was accomplished with GoTaq master mix (Promega), followed by 
thymine/adenine-cloning. The modified full-length hdc cDNA was cloned into a 
pGEM-Teasy vector and sequenced. It was inserted into a pMC vector at the EcoRI 
and SpeI restriction enzyme sites (Fink et al. 2006). Capped RNA (mRNA) was 
synthesized with T7 mMESSAGE mMACHINE (Ambion) after linearization of the 
cloned plasmid with a NarI and purified with Qiagen RNeasy Mini Kit (Qiagen), 
after DNase I digestion for removing template DNA. The purified capped hdc RNA 
(mRNA) was injected into the yolk of embryos at the 1–4 cell stage. 
4.6.4 Quantitative real-time polymerase chain reaction (III, IV) 
RNA was isolated from 30 pooled 5 dpf larvae using a Qiagen RNeasy® Mini Kit, 
following the protocol supplied by the manufacturer (Qiagen). RNA quality and 
amount were analyzed spectrophotometrically and cDNA was prepared by 
SuperScript III® (Invitrogen), primers used for qPCR were the following: hcrt A 
(NM001077392) forward 5’-TCTACGAGATGCTGTGCCGAG-3’ and reverse 5’-
CGTTTGCCAAGAGTGAGAATC-3’ (Kaslin et al. 2004), galanin (NM_015973) forward 
5’-GACCAACTGATACTCAGGATGCA-3’ and reverse 5´-
ATCCCGAGTGTTTCTGTCAGAA-3’, and β-actin (AF057040) forward 5’-
CGAGCAGGAGATGGGAACC-3’ and reverse 5’-CAACGGAAACGCTCATTGC-3’ (Keegan 
et al. 2002). 
4.6.5 Touchdown RT-PCR for identification of mutation in psen1-/- (IV) 
Adult WT and psen1-/- (hu2547) zebrafish were anesthetized in clove oil and 
genomic DNA was isolated from finclips with buffer (50 mM KCl, 2.5 mM MgCl, 10 
mM Tris-HCl, 0.45% NP40, 0.45% Tween 20, 0.01% gelatine, and 1.6 µg/ml 
poteinase K). For identification of the mutation, standard touchdown RT-PCR was 
performed with the following primer pairs: forward 5’-GAAACCCATTTGGGAAGTG-
3’ and reverse 5’-AAATACAAGCCTACACACAACC-3’, and forward 5’-
AGGAAACAGCTATGACCAT GAACGCAGAAGAATGAACG-3’ and reverse 5’-
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TGTAAAACGACGGCCAGT CAAGTTTGACATTTGCATGG-3’. The mutation was located 
to exon 5, where it induced a premature stop codon.  
4.7 Sequence comparisons and analysis of histamine receptors (I) 
Multisequence alignments were performed, using ClustalW on Web pages 
provided by the European Molecular Biology Laboratory-European Bioinformatics 
Institute, Hixton, Cambridgeshire, UK, and the sequence analyses were carried out 
with the GENSCAN Web server at Massachusetts Institute of Technology, 
Cambridge, MA, USA. Sequence comparisons were carried out with ALIGN 
provided by European Molecular Biology Laboratory-European Bioinformatics 
Institute. 
4.8 [125I]iodoaminopotentidine binding to hrh2 (I) 
[125I]iodoaminopotentidine was synthesized as described (Leurs et al. 1994) and 
was a kind gift from Professors Leurs and Timmerman (Vrije Universiteit).  
4.9 Whole-mount in situ hybridization (III, IV) 
Zebrafish MAO (AY185211) (Anichtchik et al. 2006), hcrt (NM_001077392) (Kaslin 
et al. 2004), hrh1 and hrh3 (DQ647806 and DQ647807) (Peitsaro et al. 2007) were 
cloned into pGEM-Teasy vector as described earlier. The partial coding region of 
hdc (NM001102593) (Yokogawa et al. 2007) was cloned into pGEM-Teasy vector, 
using forward 5’-GCAGCCGCAGGAGTACATGC-3’ and reverse 5’-
GGCTGCCGGGTCACGACT-3’ primers. gad1 (NM194419.1), gad2 (NM001017708.2), 
slc17a6a (NM001009982.1), slc17a6b (NM001128821.1), and slc17a7 
(NM001098755.1) (the last five abbreviated in the list on page 8–9) were cloned 
and were kind gifts from Dr. Higashijima (Higashijima, Mandel & Fetcho 2004) 
(State University of New York, Albany, NY, USA). The Notch1a (NP_571516.1) clone 
was a kind gift from Dr. Brand (Center for Regenerative Therapies Dresden, 
Biotechnology Center and University of Technology Dresden, Germany). Antisense 
and sense digoxigenin-labeled RNA probes were synthesized using the digoxigenin 
RNA labeling kit (Roche Diagnostics), following the instructions of the 
manufacturer. In situ hybridization was performed as previously described (Thisse 
& Thisse 2008) with some modifications as described (Chen, Priyadarshini & Panula 
2009, Kudo et al. 2009).  
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4.10 Immunohistochemistry (II–V) 
For optimal staining for histamine IHC, it was necessary to use the bifunctional 
fixative EDAC, due to the properties of the anti-histamine antibody (Auvinen & 
Panula 1988, Panula et al. 1989, 1990). For histamine IHC, the samples were fixed 
in 4% EDAC and 0.1% paraformaldehyde (PFA; Sigma-Aldrich) in 0.1 M phosphate 
buffer, pH 7.0, overnight (o/n) at +4 °C. For other antibody staining, PFA fixation (2 
or 4%) in 0.1 M phosphate buffer, pH 7.4, o/n at +4 °C was used. Brains from larval 
zebrafish were dissected after fixation and processed for IHC immediately. Adult 
brains that were intended for sectioning were incubated in 20% sucrose in 0.1 M 
phosphate buffer, pH 7.4, o/n at +4 °C, then embedded and sectioned at 20 µm 
with a Leica cryostat. The sections were stored at -20 °C until further processing 
for IHC. No sucrose treatment was performed on the brains that were processed as 
whole-mounts. The preabsorption controls for some of the primary antisera were 
reported earlier (Panula et al. 1990, Kaslin & Panula 2001, Kaslin et al. 2004). 
4.10.1 IHC with antibodies from different species on whole-mount larval brains 
(II–V) 
The following primary antibodies were used and incubated o/n at +4 °C: rabbit 
anti-histamine 19C (Panula et al. 1990) 1:10 000, mouse anti-TH 1:1000 
(LOT22941, DiaSorin Inc.), rabbit anti-serotonin 1:1000 (S5545, Sigma-Aldrich), 
rabbit anti-active caspase 3 1:500 (clone C92-605, 559565, BD Biosciences), rabbit 
anti-hcrt A 1:1000 (AB3704, Millipore/Chemicon), rabbit anti-β-catenin (clone 
2206, LOT056K4763, Sigma-Aldrich), and rabbit anti-galanin antibody 1:1000–
1:5000 (AB1985 and AB5909, Millipore/Chemicon). The secondary antibodies were 
highly cross-purified Alexa-fluorophore-conjugated goat antirabbit or antimouse 
antibodies (with 488, 561, or 647 fluorophores; Molecular Probes) incubated o/n 
at +4 °C.  
4.10.2 IHC on whole-mount adult brains (II, IV) 
IHC on whole-mount adult brains was performed as for larval brains; the only 
difference was that the incubation times were prolonged (primary antibody 
incubations 2–4 days). The following primary antibodies were used: rabbit anti-
histamine 19C (Panula et al. 1990) 1:10 000, mouse anti-TH 1:1000 (Diasorin Inc.), 
and rat anti-serotonin 1:250 (MAB352, Millipore/Chemicon). The secondary 
antibodies were highly cross-purified Alexa-fluorophore-conjugated goat 
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antirabbit, antimouse and/or antirat antibodies (with 488 or 561 fluorophores; 
Molecular Probes). 
4.10.3 IHC with two antibodies from the same species on cryosections (II, III) 
A tyramide signal amplification kit (TSA kit; PerkinElmer Life and Analytical 
Sciences) was used to enable double-staining of samples with primary antibodies 
from the same species. The preabsorption controls are listed in Table 2. IHC with 
TSA was performed according to the manufacturer's instructions. After the TSA-
IHC, the samples were stained to obtain the desired double-staining and mounted 
in 1:1 glycerol in phosphate-buffered saline. 
Table 2. Preabsorption controls for the antibodies used in the cotransmitter study (more 
detailed information can be found in II). 
Preabsorption controls 
Antigen Preabsorption 
conjugate/peptide 
Manufacturer,  
catalog number 
Dilution used  
(of conjugate/peptide) 
GABA GABA-sOVA Karhunen et al., 1993 20 µg/ml 
Galanin Human galanin peptide BACHEM, H-8230 10 µM 
Galanin Porcine galanin peptide BACHEM, H-1365 50µM 
Histamine Histamine-sOVA Panula et al., 1984 2 µg/ml 
mENK mENK peptide Sigma-Aldrich, E-5757/ M-
6638 
100 µM 
TRH TRH peptide Pennisula Laboratories, H-
4915 
10 µM 
 
The following primary antisera and antibodies were used: rabbit anti-histamine 
19C 1:50 000 (Panula et al. 1990), rabbit anti-GABA 1H 1:1000 (Karhunen et al. 
1993), rabbit anti-TRH #4319 1:1000 (Airaksinen et al. 1992), rabbit anti-mENK #36 
1:1000 (Airaksinen et al. 1992), rabbit anti-hcrt A 1:1000 (AB3704, 
Millipore/Chemicon), and rabbit anti-galanin antibodies 1:1000–1:5000 (AB1985 
and AB5909, Millipore/Chemicon). The secondary antibody was a biotinylated goat 
antirabbit antibody 1:750 (Vectastain ABC kit, Vector Laboratories Inc.). Avidin-
conjugated Texas Red (Vector Laboratories) 1:500 and streptavidin-conjugated 
fluorescein 1:50 (Molecular Probes) and highly cross-purified Alexa-fluorophore-
conjugated goat antirabbit antibodies (with 488 or 561 fluorophores, Molecular 
Probes) were used to visualize the primary staining. 
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4.10.4 Enzyme histochemistry and activity assay (V) 
An MAO oxidase enzyme histochemistry and activity assay was carried out, as 
described (Anichtchik et al. 2006).  
4.11 High-pressure liquid chromatography 
4.11.1 Catecholamine and serotonin HPLC (V) 
Catecholamines and their metabolites were measured from snap-frozen samples 
that had been stored at -80 °C. A total of 15–25 larvae were pooled and 
homogenized in 150 μl of cold solution containing 0.4 M perchloric acid, 0.1% 
Na2S2O5, and 0.1% ethylenediaminetetraacetic acid. After centrifugation, an 
aliquot of the supernatant was injected into the HPLC system. The HPLC system 
that was used for dopamine, noradrenaline, adrenaline, 3,4-dihydroxyphenylacetic 
acid, 5-HIAA and 3-methoxytyramine measurements comprised a Waters pump 
model 515 (Waters Corporation), Waters Autosampler 717plus, and an ESA 
Colochem 5100A electrochemical detector (ESA). The HPLC system used for 
serotonin measurements included a Waters pump model 510, Waters 
Autosampler 717plus and Concorde electrochemical detector (Waters 
Corporation). 
4.11.2 Histamine HPLC (III) 
Histamine was assayed with HPLC, as described earlier (Eriksson et al. 1998). 
Briefly, samples were collected by pooling 10 or 30 larvae from which the eyes and 
tails were removed. These samples were frozen on dry ice and stored at -80 °C 
until further processing for HPLC. The samples were then homogenized by 
sonication in 2% perchloric acid, centrifuged for 30 min at 15 000 g at +4 °C, and 
filtered through a 0.45 µm polyvinylidene diflouride filter (Pall Life Sciences) before 
loading into the HPLC system. The protein concentration was measured by the 
BCA-kit (Thermo Fisher Scientific Inc.) to normalize the results from HPLC 
measurement. 
4.12 Microscopy 
Samples of MAO WISH were examined, using an Olympus microscope (Olympus 
Corporation) connected through a charge-coupled device camera to the AnalySIS 
software (Soft Imaging Software GbmH). WISH samples of hdc, hrh1, hrh3, hcrt, 
gad1, gad2, slc17a6a, slc17a6b, and slc17a7 were analyzed with an inverted Leica 
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DM IRB microscope. The images were acquired with a Leica DFC490 camera and 
Leica Application Suite, MultiFocus option (Leica Microsystems). 
The IHC samples were all analyzed with a Leica TCS SP2 AOBS confocal microscope. 
The excitation wavelength of the argon laser for samples visualized with 
streptavidin-fluorescein and the Alexa 488 fluorophore was 488 nm and the 
emission was collected at 500–550 nm. The excitation wavelength of the diode 
laser used for samples stained with the Alexa 568 fluorophore was 561 nm and the 
emission was collected at 600–700 nm (narrower emission spectra when triple-
staining was used to prevent overlap). A helium/neon laser was used to excite the 
Alexa 647 fluorophore at 633 nm and the emission was collected at 640–750 nm. 
In all cases, sequential scanning between the frames and frame averaging were 
applied to minimize cross-talk between the channels. For the 3D analysis, the 
optimal step size calculated by the Leica software was applied.  
4.13 Image analysis 
The brains were scanned with optimized step size and averaging to allow 3D 
rendering of the data in Imaris software (Bitplane AG). In general, maximum 
projections of the stacks acquired were produced with Leica software for 
comparative analysis. The images were further processed using ImageJ or Fiji. All 
processing was applied to whole images. The 3D-rendered images were exported 
as snapshots and as video files. Quantification of the histamine neuron number 
was done by counting the neurons from all the stacks of images that had been 
acquired and scanned with optimal settings.  
For the colocalization study (II), a single sagittal section was studied from each 
adult zebrafish brain. The section with the most histamine-immunoreactive 
neurons was chosen. All the histamine-immunoreactive neurons were counted, as 
well as the number of cells containing both histamine and the other neuronal 
markers of interest. We were interested in which neurotransmitters are 
colocalized with histamine in histaminergic neurons, and not the surrounding 
fibers. Thus, we counted the neurons and utilized no software for assessing 
colocalization, because it would have detected each pixel and not distinguish 
between the fibers and the somata of the neurons. Single focal planes of the 
overlay images were analyzed for colocalization with Leica software or open-
source image analysis software Fiji (http://pacific.mpi-
cbg.de/wiki/index.php/Main_Page). The maximum projections of the stacks 
acquired were produced with Leica software for comparative analysis.  
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The anatomical structures were identified and/or numbered, using the atlas of the 
adult zebrafish brain (Wullimann, Rupp & Reichert 1996), and the atlas based on 
the location of the aminergic neurons in adult zebrafish (Kaslin & Panula 2001). All 
pictures were compiled into panels in CorelDraw (Corel Corporation). 
4.14 Statistical methods 
For statistical analysis between two groups, the Student’s t-test or Mann-Whitney 
U-test were used (GraphPad Prism Software or Microsoft Office Excel 2007). For 
statistical analysis between several groups, one-way analysis of variance (ANOVA) 
was applied with Tukey’s Multiple Comparison post hoc test in GraphPad. To 
assess the interaction between time and treatment two-way repeated measures 
(RM) ANOVA was applied to the material in GraphPad Prism. The graphs were 
plotted as mean values and the variation was indicated with standard error of the 
mean (SEM), unless otherwise described.  
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5 Results 
Please consult the original publications in the appendix for more detailed 
information. 
5.1 Identification and characterization of the histamine receptors in 
zebrafish and the behavioral effects of their ligands (I, III) 
The innervation pattern of the histaminergic neurotransmitter system was studied 
previously in zebrafish (Eriksson et al. 1998, Kaslin & Panula 2001). In contrast, the 
distribution of the histamine receptors has so far been unknown in zebrafish and 
the specific site of action for histaminergic innervation is unknown in any species. 
Thus, a detailed map of the distribution of the receptors could reveal the site of 
action of the histaminergic neurons. The mRNA of the three histamine receptors 
hrh1, hrh2, and hrh3, were already expressed from 3 hpf onwards in the 
developing zebrafish embryo, as detected with RT-PCR. Histamine receptor mRNA 
in situ hybridization revealed expression patterns in different parts of the zebrafish 
brain (Figure 8). hrh1 was mainly expressed in the dorsal telencephalon, with low 
levels of expression in the ventral telencephalon and diencephalon of larval fish 
brain. hrh2 binding was detected with [125I]iodoaminopotentidine in adult fish 
brain sections in the optic tectum, brainstem, and caudal hypothalamus, which 
also harbors the histaminergic hdc-positiv, neurons. The receptor with the most 
restricted neuronal expression pattern was hrh3, being located only in the dorsal 
telencephalon and ventrocaudal hypothalamus of larval zebrafish. Furthermore, 
we identified the histamine receptor-dense area as glutamatergic, because 
markers for the glutamatergic neurons were mainly found in the dorsal 
telencephalon and the GABAergic markers in the ventral telencephalon.   
 
Figure 8. Histamine receptor expression in the zebrafish brain. Lateral view of the brain. 
The hrh3 mRNA had the most restricted expression pattern, whereas hrh1 mRNA was 
expressed both in the telencephalon and diencephalon. The data is a merged presentation 
of the findings in I and III. 
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To assess the functionality of the receptors, the zebrafish larvae were treated with 
histamine receptor ligands. Treatment with different concentrations of the hrh1 
antagonist pyrilamine, hrh2 antagonist cimetidine, and hrh3 inverse agonist 
thioperamide and hrh3 agonist immepip resulted in altered behavior, which 
suggested that the receptors were functional. Each of the histamine receptor 
ligands tested significantly reduced the locomotor activity of zebrafish larvae 
during a short 10 min tracking period, whereas the turn angle of the fish was not 
altered. Pyrilamine at the highest dose, 100 µM, caused the strongest effect 
compared with that of control animals (p ≤ 0.001). Surprisingly cimetidine 
decreased the movement at all doses in comparison to that of control animals (1 
µM, p ≤ 0.05, 10 µM, p ≤ 0.05 and 100 µM, p ≤ 0.001). Both thioperamide and 
immepip strongly affected on movement with the highest dose (100 µM, p ≤ 0.001 
and p ≤ 0.05, respectively), compared with the control animals.  
5.2 Cotransmitters of the histaminergic neurons (II, III) 
A quantitative comparison of the histaminergic system in the brains of adult male 
and female zebrafish was done to rule out sex-related differences in the animals. 
No significant difference between the sexes was found (p ≤ 0.57) and therefore 
further studies were done on groups of fish in which both sexes were represented. 
To assess the similarity of zebrafish histaminergic neurons with other species, the 
cotransmitters of these cells were studied. We found that the pattern of the 
various neurotransmitters in zebrafish was similar to that documented in rats 
(Airaksinen et al. 1992). Galanin was the most commonly observed neuropeptide 
that coexists with histamine, since about 30% of the histaminergic neurons 
observed were positive for both markers. GABA and histamine were colocalized in 
14% of the neurons and TRH coexisted with histamine in about 7% of the neurons. 
mENK and hcrt were never observed to coexist with histamine.  
In the whole-mount adult brain, the contacts between the histaminergic system 
and the serotonergic and dopaminergic systems were assessed. Histamine neurons 
surround the caudal zone of the periventricular hypothalamus (Hc), which harbors 
both serotonergic and dopaminergic neurons (Kaslin & Panula 2001). Histamine-
immunoreactive fibers are scarce in the region that harbors the serotonergic and 
dopaminergic neurons. We observed that the histaminergic fibers innervated only 
the ventrolateral part of the Hc. 
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5.3 Histaminergic system in alertness/wakefulness (III) 
Histamine neurons are active during the waking period and silenced during sleep 
(Lin et al. 2011). Translation inhibition of hdc, which is essential for the conversion 
of the amino acid ι-histidine to histamine, with MOs resulted in significantly lower 
histamine levels in zebrafish larvae at 5 dpf when morphants were compared with 
control animals (75% reduction in hdc MO group, p ≤ 0.05). Furthermore, the 
histamine immunoreactivity was almost completely abolished in hdc MO-injected 
animals, compared with both WT controls and std MO-injected fish. At 24 hpf and 
6 dpf, the hdc MO-injected fish showed no abnormal gross phenotypes. At 5 dpf, 
cell death was not increased, nor was any defects observed in other related 
neurotransmitter systems, such as the dopaminergic system. Inhibition of hdc 
impaired locomotor activity during the light period (Figure 9). Two-way RM ANOVA 
revealed a significant interaction between the WT and hdc MO groups (p ≤ 0.001, 
Figure 9), whereas the std MO did not induce a significant effect. These results 
indicate that the effect was specific to the hdc MO. 
 
Figure 9. Transient inhibition of hdc induced a decline in locomotor activity during the light 
phase of a 24-h period in 5–6 dpf old larvae. Findings compiled from III. 
Since the activity of the larvae was altered during the light period, we 
hypothesized that the decreased activity would be due to attenuated alertness 
rather than a motor dysfunction. We assessed the optomotor response of the hdc 
MO-injected fish and found that it was not significantly altered compared with that 
of WT siblings. To assess whether the decreased activity attenuated alertness, we 
subjected the zebrafish larvae to periods of lights on and off. The dark-induced 
flash response (consisting of an O-bend (Burgess & Granato 2007a)) is elicited in 
WT fish as a response to the onset of the dark period and lasts for less than a 
second. Inhibition of hdc interfered with the response of larval fish to 
environmental cues and the dark-induced flash response was therefore impaired in 
hdc MO-injected fish when compared with noninjected WT control fish (Figure 10). 
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This difference was confirmed by a significant time and treatment interaction (p ≤ 
0.05, Figure 10) when WT and hdc MO fish were compared. In line with these 
observations, the same impairment of the response to environmental cues could 
be detected when WT larvae were treated with the hrh1 antagonist pyrilamine (p ≤ 
0.001, Figure 10). The dark-induced flash response was recovered in hdc MO-
injected larvae that were coinjected with hdc mRNA (p>0.05).   
 
Figure 10. Histamine drives the dark-induced flash response in larval zebrafish in a hrh1-
dependent manner. The data are compiled from III. 
The strongest mRNA expression of hrh1 was detected in the dorsal telencephalon 
of larval zebrafish and this area is highly innervated by histaminergic afferent 
fibers. We hypothesized that the dorsal telencephalon would be the main area 
that controls alertness-associated behavior. To further study the neuronal circuits 
that underlie this behavior, we traced the connections of the dorsal telencephalon 
by injecting a lipophilic dye, DiI, into this area. We found that the fibers from the 
dorsal telencephalon innervated the histaminergic ventrocaudal hypothalamus. 
The distribution of TH-immunoreactive neurons was used as an anatomical map to 
locate the targets of the DiI-labeled fibers. No fibers were positive for both DiI and 
histamine. This fact supports the idea that the target area of the dorsal 
telencephalon would indeed be the ventrocaudal hypothalamus, since it was not 
the histaminergic fibers per se that were labeled with DiI.  
5.4 γ-Secretase regulates the development of histamine neurons (IV)  
The histaminergic neurons play an important role in alertness and many 
neurological disorders (Haas, Sergeeva & Selbach 2008). However, little is known 
about which factors mediate the development of this system. We found that, 
when γ-secretase functioning is disturbed due to a loss of function mutation in 
psen1, the development of the histaminergic neurotransmitter system was altered 
(Figure 11). Expression analysis of hdc mRNA at 7 dpf revealed significantly fewer 
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hdc-positive neurons in psen1-/- than in WT controls (p ≤ 0.001). Similarly, at 7 and 
8 dpf the histamine-immunoreactive neuron number in the psen1-/- fish was lower 
than in WT fish (p ≤ 0.001 and p ≤ 0.01, respectively).  
 
Figure 11. Loss of function mutation of psen1, which is part of the γ-secretase complex, 
impaired the development of the histaminergic neurotransmitter system at the larval 
stage. DAPT treatment induced the same phenotype. The γ-secretase complex consists of 
PSEN1, nicastrin, APH-1, and PEN-2. The psen1 mutant zebrafish carries a premature stop 
codon in the third extracellular loop. The part of psen1 that is missing in the mutant is 
visualized in the image as a dotted line. Unpublished results, IV. 
The same impairment of development of the histaminergic neurons was found 
when larval zebrafish were treated with an inhibitor of γ-secretase, DAPT (Figure 
11). DAPT treatment for 1–5 dpf negatively affected development of the 
histaminergic neurons and when compared with WT and DMSO treated siblings 
there were significantly fewer histamine-positive neurons in the DAPT-treated 
animals (p ≤ 0.05). A shorter treatment time with DAPT from 6–8 dpf had the same 
effect on development of the histaminergic system (p ≤ 0.05).  
To verify that psen1-/- specifically affected the development of the histaminergic 
system, we also assessed the development of the galaninergic (mRNA and protein 
level) and dopaminergic (by TH-IHC) systems. There was no difference in the 
development of these systems when WT and psen1-/- animals were compared at 7 
dpf. Furthermore, we could not detect an increase in cell death in the psen1-/- 
compared with the WT siblings. 
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5.5 Neuronal plasticity and the histamine system (III, IV) 
We found that in psen1-/- zebrafish the histaminergic neurotransmitter system 
was temporally and spatially altered in the brain compared with WT fish (Figure 
12). At the larval stages, fewer histamine-positive neurons in the psen1-/- fish 
were observed than in the WT (p ≤ 0.001). At increasing age, the difference 
between the WT and the mutants was reduced. In 2-month-old animals, the 
histamine neuron number in the psen1-/- fish was not significantly different from 
that in the WT (p > 0.05). This state was not stable and changed with time, since 
the histamine neuron number was significantly (about 30%) increased in psen1-/- 
fish compared with the WT controls (p ≤ 0.001) when the animals were 1 year old 
(Figure 12). 
 
Figure 12. The development of the histaminergic neurotransmitter system is temporally 
altered in psen1-/- zebrafish. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. Unpublished results, IV. 
At the age when the psen1-/- fish had significantly lower numbers of histaminergic 
neurons, the behavior of the animals was also changed. At 6 dpf the psen1-/- 
larvae failed to exhibit the dark-induced flash response, a histamine-mediated 
behavior. Furthermore, at 7 dpf the psen1-/- larvae swam significantly less than 
the WT fish (p ≤ 0.001). The locomotor activity of adult psen1-/- fish was unaltered 
compared with the WT controls. However, the mutants exhibited an increased 
thigmotaxis (p ≤ 0.05), since they avoided the inner zone of the arena. The 
behavioral phenotypes were associated with the changes in the histaminergic 
system.  
After hdc knockdown, we found that the hcrt system did not develop as in WT 
siblings. Histamine regulated the development of the hcrt neurons, since hdc MO-
injections reduced hcrt mRNA, as measured both by in situ hybridization (Figure 
13, p ≤ 0.05, WT and hdc MO) and qPCR (p ≤ 0.05). The hcrt neuron number was 
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rescued when the embryos were coinjected with hdc MO and hdc mRNA. Injection 
of 800 pg of hdc mRNA alone induced an increase in the hcrt neuron number 
compared with WT controls (p ≤ 0.05).  
 
Figure 13. Rescue of hcrt neurons in zebrafish after injection of hdc mRNA. *p ≤ 0.05, **p ≤ 
0.01. The data are compiled from III. 
Treatment of WT larvae with the inhibitor of HDC, α-FMH, induced the same 
reduction in hcrt neuron number (Figure 14 b, p ≤ 0.05) that was observed after 
inhibition of hdc with MO. In situ hybridization of hcrt and hrh1 in separate 
samples revealed that these two transcripts are found in the same region (Figure 
14 a). This finding led us to question whether hcrt neurons could be regulated in a 
hrh1-dependent manner. Indeed, the regulation of the developing hcrt 
neurotransmitter system was hrh1-dependent. This was evident, because the hrh1 
antagonist pyrilamine reduced the hcrt neuron number (Figure 14 c, p ≤ 0.001).  
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Figure 14. Development of the hcrt neurons in zebrafish. a) Histamine receptor mRNA 
expression in comparison to hcrt neurons. b) Treatment of larvae with α-FMH caused 
impairment in the developing hcrt system. c) Histamine regulated hcrt neuron 
development in a hrh1-dependent manner, since the hrh1 antagonist pyrilamine interfered 
with the development of the hcrt system, *p ≤ 0.05, ***p ≤ 0.001. The data are compiled 
from III. 
5.6 Monoamine oxidase affects locomotor activity via serotonin (V) 
In zebrafish, MAO is found in dopaminergic, serotonergic, and histaminergic 
neurons (Sallinen et al. 2009). The role of MAO was assessed in amine-driven 
behaviors, such as locomotor activity. Chronic (0–7 dpf) treatment of zebrafish 
larvae with the MAO inhibitor ι-deprenyl reduced the locomotor activity of larval 
zebrafish in a dose-dependent manner at 7 dpf. When the larvae were allowed to 
recover for 2 days, the behavior also returned to the level of the controls. Acute (2 
h) treatment just prior to assessment of behavior induced a significant decline in 
movement. We also assessed the vertical place preference in a water column of ι-
deprenyl-treated larvae and found that these swam closer to the water surface 
than the controls (p ≤ 0.0001). Interestingly, we found that inhibition of MAO 
increased the serotonin content 100-fold, but did not affect the metabolism of 
other amines (dopamine and noradrenaline) that were measured with HPLC. The 
increase in serotonin was associated with a decline in locomotor activity and an 
increase in ectopic serotonin-positive neurons (Figure 15).  
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Figure 15. MAO drives serotonin-mediated behaviors in larval zebrafish. ι-Deprenyl inhibits 
MAO and thereby the conversion of serotonin to its metabolite, 5-HIAA. This causes an 
increase in serotonin concentration and decrease in locomotor activity. PCPA is an inhibitor 
of TPH and by exposure of larvae to both chemicals (ι-deprenyl and TPH), PCPA inhibits the 
elevation of serotonin. The data are compiled from V. 
To verify whether serotonin was responsible for the phenotypes observed, we 
treated larvae with drugs that interfere with serotonin synthesis (TPH inhibitor 
PCPA) and uptake (selective serotonin reuptake inhibitor fluvoxamine). The 
behavioral deficit was rescued by treatment of the ι-deprenyl-exposed larvae with 
PCPA. HPLC analysis revealed that PCPA treatment rescued the effect that ι-
deprenyl had on serotonin increase and therefore allowed serotonin to remain at 
control levels. The ectopic serotonin-positive neurons were abolished when the ι-
deprenyl-treated animals were treated with the selective serotonin reuptake 
inhibitor fluvoxamine.  
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6 Discussion 
6.1 The methods – drawbacks and strengths 
To date, there are several available zebrafish strains; however the interstrain 
differences have not been studied extensively. In zebrafish, the differences in the 
genetic backgrounds of the various WT strains do not affect spontaneous 
locomotor activity (Bretaud et al. 2011). The zebrafish strain that was used for four 
of the publications in this thesis has previously been used in several studies 
(Eriksson et al. 1998, Kaslin & Panula 2001, Kaslin et al. 2004, Anichtchik et al. 
2006, Sallinen et al. 2009, 2010, Perala et al. 2010) and the behaviors observed for 
the adult and larval fish are reproducible (above-mentioned publications 
compared with results in I–IV). 
Genetic manipulation of gene expression can either be transient through MOs or 
then stable by induction of mutations into genomes, followed by forward or 
reverse genetic screening of the animals for mutations. At a glance, the MO 
approach seems to be the easiest. The main strength with MOs is that they 
constitute a quick and inexpensive approach to study the function of specific 
genes. The main problem is that many of the MOs have short-lasting effects that 
are no longer effective when the fish are 1-week-old and start to exhibit 
quantifiable behaviors. Furthermore, many MOs induce unspecific off-target 
effects and therefore it has been stressed that several MOs should be used to 
reproduce the phenotypes of interest (Robu et al. 2007). We did this, but found 
that the splice site blocking MOs did not recapitulate the phenotype observed with 
initiation site blocking MOs, although the phenotype was phenocopied by other 
means of intervention of histaminergic signaling (III). Therefore many different 
approaches to recapitulate the same phenotype provide a good approach. The 
behavioral analysis was done mainly in 1-week-old larval zebrafish. At this age, the 
fish already hunt for food, since they have consumed the nutrients from the yolk 
sac, and show many quantifiable behaviors. The drugs can be taken up at this late 
stage (I, III), because the blood-brain barrier of the zebrafish is not fully functional 
at 7 dpf and the initiation site blocking MO we used was still effective at this age 
(III). The behavioral effects observed were therefore due to the MO and/or 
pharmacological interventions used. In the behavioral experiments, the number of 
individuals used per group in each experiment was quite high and was needed to 
reduce the standard deviation and variation seen within the groups. This is one of 
Discussion 
 
57 
 
the major drawbacks with the behavioral assay approach, but can quite easily be 
circumvented since fish lay many eggs per clutch. 
IHC with two primary antibodies from the same species was used in the 
colocalization study (II). The drawback of this approach is that we had to use 
antibodies from the same species, which could have resulted in some false-positive 
detection. This approach worked, because we used the appropriate controls 
required. We also ensured that there was no overlap between the light paths, 
neither excitation nor emission, of the confocal microscope. While scanning the 
images, care was taken to ensure that the best possible resolution was used and 
also that the averaging of each channel was performed to reduce background 
interference and thereby excess detection. In a few cases, deconvolution was 
applied to the images, but we observed that this did not affect the final outcome 
of the image, suggesting that the IHC staining procedure and confocal microscope 
settings were optimal.  
6.2 Neuronal circuits underlying behavior (III, V) 
In this thesis, we observed that histamine and serotonin affected behavior. We 
found that hdc knockdown abolished the dark-induced flash response and that 
pharmacological inhibition of hrh1 resulted in the same behavioral phenotype. 
These results indicated that histamine via hrh1 is an important mediator of rapid 
behavioral responses that are elicited by sudden changes in the environment. In 
agreement with our results, studies using hdc knockout mice have shown that in 
situations when increased alertness is required, hdc knockouts fail to respond 
(Ohtsu et al. 2001, Parmentier et al. 2002, Dere et al. 2004). Knockout of hrh1 in 
mice results in reduced locomotor activity (Inoue et al. 1996). Contrasting results 
have been reported in rats, since hrh1 antagonism with pyrilamine increases the 
startle response and attenuates prepulse inhibition (Roegge et al. 2007). This 
discrepancy between the genetic and pharmacological models may be due to 
differences in uptake of or sensitivity properties of the hrh1 ligand. The dorsal 
telencephalon showed the highest hrh1 and hrh3 mRNA expression in zebrafish. 
The expression patterns of inhibitory GABAergic and excitatory glutamatergic 
neuron markers revealed that the dorsal telencephalon was mainly glutamatergic. 
IHC analysis showed that the dorsal telencephalon in zebrafish larvae also harbors 
GABAergic neurons (Perala et al. 2010). Taken together, these data suggest that 
hrh1 and hrh3 are mainly expressed in glutamatergic postsynaptic 
nonhistaminergic neurons in the dorsal telencephalon in zebrafish. Previous 
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studies with mammals showed that histamine receptors are expressed in a laminar 
manner in the cortex of rodents (Pillot et al. 2002a, Haas, Sergeeva & Selbach 
2008) and humans (Jin & Panula 2005, Jin, Anichtchik & Panula 2009). The dorsal 
telencephalon of the zebrafish brain is highly innervated by histaminergic fibers 
(Kaslin & Panula 2001). Our tract-tracing study of the projections from the dorsal 
telencephalon with the lipophilic dye DiI revealed that the fibers terminated in the 
histaminergic ventrocaudal hypothalamus and other areas in zebrafish. None of 
the fibers were doubly positive for both DiI and histamine. Antero- and retrograde 
tracing identified the limbic telencephalon as the main input area in rat 
histaminergic tuberomammillary neurons (Ericson, Blomqvist & Kohler 1991). Only 
a few fibers were reported to enter the core of the TMN (Ericson, Blomqvist & 
Kohler 1991) in the same manner as we observed in zebrafish. Based on these 
data, we propose that in zebrafish a hypothalamic-telencephalic loop exists that 
mediates the alertness-associated behavior we observed as a dark-induced flash 
response. 
In larval fish, lack of histamine affected alertness-associated behavior, whereas 
inhibition of MAO with ι-deprenyl increased mainly serotonin and reduced 
locomotion. In mammals, the main substrate for MAO is dopamine, which is one of 
the amines that mediate locomotion. PD is a result of degeneration of the 
dopaminergic neurons in the substantia nigra. The main symptom of PD is the 
motor deficit that emerges when a large proportion of the niagral dopaminergic 
neurons have died. Modeling PD with neurotoxins in zebrafish causes a locomotor 
deficit that can be partially rescued by ι-deprenyl treatment (Sallinen et al. 2009). 
Deprenyl-mediated inhibition of MAO in rats elevated dopamine levels (Molinengo 
& Ghi 1997), whereas in zebrafish we found that the main substrate for MAO was 
serotonin. In humans, altered serotonin levels are associated with depression, 
anxiety, and the serotonin syndrome. The serotonin syndrome is caused by 
increased levels of serotonin in the brain, leading to consciousness impairment, 
including coma, agitation, rigidity, and tachycardia (Radomski et al. 2000, Ables & 
Nagubilli 2010). Administration of the serotonin receptor agonist into the raphe 
nucleus in rats reduced spontaneous locomotor activity (Hillegaart 1990) and 
injections into the periventricular nucleus of the hypothalamus increased inactivity 
(Osei-Owusu et al. 2005). The effect is thought to be mediated via reduced activity 
of the serotonergic projections in areas controlling motor function in the 
telencephalon (Hillegaart 1990). In our experiments, inhibition of MAO with ι-
deprenyl increased the serotonin level in the brains of zebrafish larvae and was 
associated with increased heart rate, reduced locomotion, and preference for 
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remaining close to the water surface. The reduction in movement could be dose-
dependently reversed when the larvae were treated with a TPH inhibitor. 
Furthermore, the increase in serotonin level measured by HPLC was associated 
with expression of ectopic serotonin-immunoreactive neurons in the ventral 
hypothalamus. Treatment with a selective serotonin reuptake inhibitor, 
fluvoxamine, restored the neuron phenotype by abolished ectopic serotonin 
immunoreactivity. Taken together, uptake of serotonin in ectopic neurons of the 
ventral hypothalamus induced a behavioral alteration that could be restored by 
normalized serotonin levels.  
Based on tract tracing and IHC data, we found afferent and efferent projections 
that provided connections between the dorsal telencephalon and the ventrocaudal 
hypothalamus. This telencephalo-hypothalamic loop may be crucial for execution 
of motivated behaviors. Recent studies in zebrafish have identified specific brain 
areas that are involved in mediating certain behaviors. For example, filtering of 
visual information in the optic tectum by GABAergic interneurons is important in 
prey capture behavior (Del Bene et al. 2010). Interestingly, hrh1 (Yanai et al. 1998) 
and hdc knockout (Dere et al. 2004) in mice cause increases in serotonin turnover. 
These rodent data interlink the role of reduced histamine via hrh1 signaling with 
an increase in the serotonin metabolite 5-HIAA. The increase in 5-HIAA 
concentration was only observed in the brainstem of hrh1 knockout mice, whereas 
the turnover rate of 5-HIAA/serotonin was increased in the telencephalon, 
hippocampus, mesencephalon, and brainstem (Yanai et al. 1998). In hdc knockout 
mice, serotonin turnover was increased in the frontal cortex, a brain area linked 
with attention and alertness (Dere et al. 2004). Collectively, the results from our 
study provide novel data regarding two neuronal circuits by which specific 
aminergic neurotransmitter systems affect neuronal plasticity and specific 
behaviors in the zebrafish.  
6.3 The histaminergic system in zebrafish compared with that in 
mammals (I–III) 
Histaminergic neurons are important in mediating various behavioral responses. 
Therefore, it was important to study which neurotransmitters colocalize with 
histamine and how similar the neurons of zebrafish are in comparison with 
mammalian histaminergic neurons (data summarized in Table 3). First, we 
quantified the histaminergic neuron number in both female and male adult 
zebrafish brain and observed no differences between the sexes. This allowed us to 
use both males and females for the cotransmitter analysis without taking into 
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account the gender difference. We found that the cotransmitters of histamine in 
histaminergic neurons are galanin, GABA, and TRH. A previous study of 
histaminergic neurons revealed that there are discrepancies between different 
rodent species (Airaksinen et al. 1992). In rats, the cotransmitters of histaminergic 
neurons are galanin, GABA, and TRH (Airaksinen et al. 1992). In mice the 
neurotransmitters that coexist with histamine are galanin and GABA, whereas in 
guinea pig histamine colocalizes with GABA and mENK (Airaksinen et al. 1992). 
Only one study has addressed whether galanin and GABA are cotransmitters of 
tuberomammillary histaminergic neurons in humans and it showed that GABA 
coexists with histamine (Trottier et al. 2002). In this study on postmortem samples 
from both males and females, no galanin was found in histaminergic neurons 
(Trottier et al. 2002). Fibers of each of the neurotransmitter systems studied 
innervated the histaminergic neurons and may affect the activity of the histamine 
neurons. Previous studies in rodents have shown that galanin has an inhibitory 
effect on histamine release (Arrang et al. 1991) and that sleep deprivation 
increases galanin levels (Toppila et al. 1995). Furthermore, TRH excites both 
histaminergic (Parmentier et al. 2009) and hcrt neurons (Gonzalez et al. 2009). 
Interestingly, the stimulating effect of TRH is abolished in hdc knockout animals 
(Parmentier et al. 2009), which suggests that the wake-promoting effect of TRH is 
histamine-mediated. The role of mENK in the histaminergic system has not been 
studied. Galanin and GABA may form the main components of the sleep-
promoting system (McGinty & Szymusiak 2003). Neurons of these two systems are 
located in the ventrolateral preoptic nucleus. These innervate and exert an 
inhibitory effect on the activity of histaminergic neurons (Sherin et al. 1998). It has 
long been known that via this projection the GABAergic neurons regulate the 
sleep-wake cycle (McGinty & Szymusiak 2003). We also assessed the anatomical 
relationship between histamine, serotonin, and dopamine in whole-mount adult 
zebrafish brains. In this case, we found that the serotonin and dopamine neurons 
are found in the same area, which is devoid of histaminergic neurons. 
Furthermore, we could detect no neurons that were positive for both histamine 
and TH or histamine and serotonin. This is in accordance with what was reported 
from studies on sections of the adult zebrafish brain (Kaslin & Panula 2001) and rat 
(Vanhala, Yamatodani & Panula 1994). 
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Table 3. Comparison of the cotransmitters in histaminergic neurons in several species. 
References to original publications are found in the text for human, rat, guinea pig, and 
mouse. Zebrafish data presented as reported in II. 
  Cotransmitters of histaminergic neurons 
 Human Rat Guinea pig Mouse Zebrafish 
hcrt ? - ? ? - 
Galanin + + - + + 
GABA - + + + + 
mENK ? - + - - 
TRH ? + - - + 
TH ? - ? ? - 
5-HT ? -  ? ? - 
 
The histamine receptors were expressed in the zebrafish embryo from 3 hpf 
onwards and the histamine receptor subtypes were found throughout the brain. 
As in mammals (Haas, Sergeeva & Selbach 2008), zebrafish hrh1 and hrh3 were 
mainly expressed in the dorsal telencephalon. Faint expression of hrh1 was 
detected in the lateral and ventrocaudal hypothalamus and hrh3 was expressed in 
histaminergic ventrocaudal hypothalamus as well. The histamine receptors in 
zebrafish larvae seem to be functional, since ligands targeting the receptors had 
behavioral consequences in zebrafish. The behavioral consequences observed in 
zebrafish were in accordance with those reported for mice (summary in Table 4). 
In hrh1 knockout mice, spontaneous locomotor and exploratory behaviors are 
reduced during the active period (Inoue et al. 1996) and in stressful situations 
(Yanai et al. 1998). The motor coordination of hrh1 knockout animals was reported 
to be normal (Inoue et al. 1996, Yanai et al. 1998), suggesting that hrh1 may 
mediate the locomotor activities associated with emotion. In line with these 
observations, we observed a reduction in spontaneous locomotor activity after 
treatment of zebrafish larvae with pyrilamine, suggesting that the functionality of 
hrh1 was conserved between the species. hrh2 knockout mice develop normally 
and are fertile (Kobayashi et al. 2000). The CNS phenotype of hrh2 knockout mice 
results in reduced spontaneous movement, increased restlessness in familiar 
environments, since the knockouts exhibit increased rearing behavior, and lower 
susceptibility for electrically induced convulsions compared with that in WT mice 
(Fukushima et al. 2003). Similarly, in our study on zebrafish larvae, the hrh2 
antagonist cimetidine reduced spontaneous locomotor activity and movement at 
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low doses. Mice devoid of hrh3 also develop normally, are fertile, and display 
overall reduced locomotor activity and normal circadian rhythm (Toyota et al. 
2002).  
Table 4. Comparison of the rodent and zebrafish histaminergic systems. References to 
original publications regarding the mouse are found in the text. Zebrafish data presented 
as reported in I and III. 
Inhibition either via genetic (mouse) or pharmacological (zebrafish) intervention 
  Mouse Zebrafish 
hdc  Fails to respond in situations that require 
increased alertness 
Fails to respond in situations that 
require increased alertness 
hrh1  Reduced spontaneous locomotion Reduced spontaneous movement, 
impaired response to environmental 
cues 
hrh2  Reduced spontaneous movement, increased 
restlessness in familiar environments 
Reduced spontaneous movement 
hrh3  Reduced spontaneous movement Reduced spontaneous movement 
 
The activity of hrh3 affects the release of amines, neuropeptides, and other 
substances such as GABA and acetylcholine (Haas, Sergeeva & Selbach 2008), 
which is why the levels of amines and their metabolites were measured in hrh3 
knockout animals (Toyota et al. 2002). Only the histamine level was reduced in the 
cortex of hrh3 knockout mice (Toyota et al. 2002). Thioperamide, an unselective 
antagonist of hrh3, has been used in pharmacological studies in rats to increase 
wakefulness (Monti et al. 1991) and to increase turnover of histamine in the cortex 
of rats (Yates et al. 1999). Thioperamide treatment of zebrafish larvae decreased 
spontaneous movement, a result in contrast to that reported for rats. Interestingly, 
immepip which is a hrh3 agonist, reduced spontaneous locomotor activity. These 
results indicate that hrh3 antagonism/agonism in zebrafish must be further 
studied, e.g. with receptor binding and electrophysiology, to validate the exact 
properties and specificity of the hrh3 receptor. Taken together, the functionality of 
the histamine receptors in the zebrafish was generally conserved, since 
pharmacological inhibition of two of the receptors produced similar behaviors, as 
was previously described in mice. 
So far, two studies have assessed the role of histaminergic ligands in larval 
zebrafish behavior (I and III) and one study assessed the involvement of 
histaminergic ligands in sleep-wake regulation in zebrafish larvae (Rihel et al. 
2010). These findings are in line with each other and suggest that the zebrafish can 
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be used as a model to study the role of histaminergic neurons under different 
conditions.  
6.4 The potential role of histamine in neurodegenerative disease (III, IV) 
In this thesis study, deletion of psen1 led to altered development of the 
histaminergic system that persisted until adulthood. These findings linked 
abnormalities in histaminergic system development with AD associated gene 
psen1. The main symptom of AD is dementia and cognitive decline, which are due 
to progressive degeneration of neuronal tissue (Bishop, Lu & Yanker 2010). 
Histamine receptors are involved in memory formation and hrh3 antagonists have 
been implicated in improving cognitive functions (Haas & Panula 2003, Haas, 
Sergeeva & Selbach 2008). We found that in psen1-/- larvae the histaminergic 
neuron number was lower than in WT siblings. This reduced histaminergic neuron 
number was not associated with increased cell death or alterations in other 
neurotransmitter systems, such as dopamine or galanin. Notch signaling was 
earlier reported to be involved in development of the dopaminergic system in 
zebrafish (Mahler, Filippi & Driever 2010). We did not, however, observe any 
changes in the dopaminergic neurotransmitter system between the psen1-/- fish 
and WT fish. CNS defects and abnormal phenotype are characteristic of psen1 
knockout mice, which die at birth (Shen et al. 1997). We observed no major 
defects in the gross phenotype of psen1-/- larval fish compared with WT fish. The 
role of psen1 has been studied by MO in zebrafish and these studies have shown 
that transient inhibition of psen1 and psen2 affects Notch signaling to varying 
degrees (Nornes et al. 2009). Notch is a crucial regulator of neural development in 
many species (Pierfelice, Alberi & Gaiano 2011) and we found here that the 
development of histaminergic neurons was regulated via γ-secretase activity, 
which affects Notch signaling. The reduced number of histaminergic neurons in 
psen1-/- was associated with a decrease in locomotor activity and lack of robust 
response to environmental cues. We furthermore observed that the histamine 
neuron number was higher in psen1-/- at 1 year of age than in WT fish. This 
neuronal phenotype was also associated with increased thigmotaxis, suggesting 
increased alertness or anxiety. Reduced anxiety is observed in adult zebrafish 
when the histamine level in the brain is reduced with α-FMH (Peitsaro et al. 2003). 
The mechanism underlying the increase in histaminergic neurons may be increased 
proliferation. In line with this hypothesis, mutations in psen1 increase proliferation 
in mouse models of AD (Veeraraghavalu et al. 2010) and histaminergic signaling 
itself potentiates proliferation and neuronal fate in vitro (Molina-Hernandez & 
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Velasco 2008). Taken together, we found that the histaminergic system was plastic 
throughout life and that this plasticity was mediated by psen1 and Notch1a. Notch 
signaling was recently shown to control regeneration of motor neurons in adult 
zebrafish (Dias et al. 2012). Alternatively, the plasticity observed in the 
histaminergic system in this AD model could be a consequence of 
neurotransmitter respecification (Spitzer 2012). 
Furthermore, we found that histamine had a bidirectional effect on the 
development of hcrt neurons, which is the main neurotransmitter system affected 
in narcolepsy. In our studies, hdc knockdown and hrh1 antagonism resulted in 
decreased hcrt neuron number in the treated animals compared with WT siblings 
at 5 dpf. The deficit was rescued with coinjection of hdc MO and mRNA, whereas 
hdc mRNA alone led to an increase in the number of hcrt neurons. In August 2010, 
a survey was initiated due to the increased incidents of narcolepsy in Finnish and 
Swedish children and the link between Pandemrix, a H1N1 influenza vaccine, and 
the most severe form of narcolepsy, i.e. narcolepsy associated with cataplexy, was 
established in persons under 20 years of age (Dauvilliers et al. 2010, Kallweit et al. 
2011, Kornum, Faraco & Mignot 2011). Narcolepsy is thought to be an 
autoimmune disease (Scammell 2003, De la Herran-Arita, Guerra-Crespo & 
Drucker-Colin 2011). In the cerebrospinal fluid of narcoleptic patients, the 
histamine level is reduced (Nishino et al. 2009) and in hrh1 knockout animals, the 
hcrt levels are also reduced (Lin et al. 2002). Previously, it was shown that hcrt 
excites histaminergic neurons (Eriksson et al. 2001), whereas the opposite has not. 
Histamine and hcrt are responsible for different aspects of alertness, histamine for 
motivated alertness and hcrt for locomotion-mediated alertness (Anaclet et al. 
2009). Histamine is either neuroprotective (Kukko-Lukjanov et al. 2006) or 
neurotoxic (Vizuete et al. 2000). The neurotoxic effect of histamine has been 
documented in the dopaminergic neurons in the substantia nigra (Vizuete et al. 
2000).  Alternatively, histamine could exert a neurotrophic effect, since we found 
that lack of histamine interferes with the development of the hcrt system. These 
results may have implications for the use of antihistamines during pregnancy. 
Since antihistamines are widely used in the treatment of allergy and pass through 
the placenta easily from the mother to the fetus, the effect of antihistamine 
medication during pregnancy on the developing child should be studied. An 
intriguing finding linked AD pathology to hcrt a few years ago, when changes in the 
β-amyloid concentration in brain interstitial fluid was correlated with wakefulness 
in mice and infusions with hcrt increased the amount (Kang et al. 2009). Here, we 
showed that histamine affects the hcrt system that underlies narcolepsy. 
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Furthermore, we showed a spatiotemporal alteration in the histaminergic system, 
which was due to impaired psen1 function, a gene associated with AD. Therefore, 
combining knowledge of the interaction between the histaminergic and hcrt 
systems and the effect that hcrt has on the formation of β-amyloids in a circadian 
manner, could provide further information on the mechanisms underlying the 
progression of neurodegenerative diseases. 
Taken together, we identified for the first time a factor that affects the developing 
histaminergic neurotransmitter system. These results suggest that histaminegic 
neuron development is regulated by γ-secretase, and that histamine itself drives 
the development of the hcrt system. These results offer a new avenue for study of 
the etiology of AD and narcolepsy, respectively. 
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7 Conclusions 
In this thesis the role of the histaminergic neurotransmitter system in neuronal 
plasticity was examined (Figure 16).  
• We found that the histaminergic system resembles that of other 
vertebrates, since the similarity between zebrafish and rodent histamine 
receptors is reasonably high. Moreover, histaminergic ligands have 
behavioral effects on larval zebrafish that mimic previously documented 
behaviors that have been observed in mammals. 
 
• The phenotype of the histaminergic neurons in zebrafish resembles that of 
mammals, and the zebrafish histaminergic neurons have the same 
cotransmitters as the histaminergic neurons in rats.  
 
• Behavioral experiments revealed that histamine mediated the response of 
animals to environmental cues by altered alertness. We proposed that this 
rapid response, the dark-induced flash response, was partially controlled 
by the dorsal telencephalon. The dorsal telencephalon of zebrafish was 
innervated by a dense network of histaminergic fiber projections and 
expressed hrh1 and hrh3. This brain area sent afferent projections that 
terminated at the histaminergic neurons. Together these formed a 
telencephalic-hypothalamic loop. The hrh1 antagonist pyrilamine 
abolished the dark-induced flash response.  
 
• We found that histamine deficiency interfered negatively with the 
development of the hcrt system in a hrh1-dependent manner. Another 
novel finding was the identification of γ-secretase and possibly Notch 
signaling as factors that regulated the development of histaminergic 
neurons.  
 
• We found that MAO, also expressed in histaminergic neurons, mainly 
affects the metabolism of serotonin. We identified increased serotonin 
levels and ectopic serotonin immunoreactivity in the ventral hypothalamus 
as mediators of decreased locomotor activity in larval zebrafish. 
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In conclusion, the main findings in this thesis are the identification of new 
regulatory mechanisms for histamine. Firstly, we found that histamine affects the 
development of the hcrt system. Secondly, we found that the developing 
histaminergic system itself is regulated in a γ-secretase-dependent manner. These 
results are raising new important aspects of study in the etiology of 
neurodegenerative disorders, such as narcolepsy and AD. 
 
 
Figure 16. Summary of the main results presented in this thesis. Histaminergic neurons 
containing histamine (HA) and several cotransmitters project from the ventrocaudal 
hypothalamus to the dorsal telencephalon. In this area, hrh1 and hrh3 are highly 
expressed. The neurons that project from the target area of histaminergic neurons are 
mainly glutamatergic and innervate the ventrocaudal hypothalamus. In this region, 
serotonergic neurons are also found and ectopic expression of serotonin as a result of 
inhibition of MAO decreases locomotor activity. Inhibition of γ-secretase downregulates 
the histaminergic neuron number in larval zebrafish, whereas inhibition of histamine 
synthesis downregulates the number of hcrt-positive neurons in the lateral hypothalamus 
in a hrh1-mediated manner and impairs the behavioral responses to environmental cues. 
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8 Future prospects  
Tract tracing revealed a hypothalamic–telencephalic loop in zebrafish similar to 
that detected in rodents (Ericson, Blomqvist & Kohler 1991). Recently, a study 
reported that the Dc in zebrafish could be the mammalian cortex equivalent 
(Mueller et al. 2011). Further studies in comparative neurology and hodology that 
can be correlated with behavioral outputs are needed for a better understanding 
of neuronal functions in the zebrafish brain. Although the MO approach was 
successful in this study, knockout of hdc by TILLING, Gal4/UAS, ZFN, or TALEN 
would provide favorable additional models for assessing the role of hdc and the 
histaminergic system in development and disease. Furthermore, the role of MAO 
in histaminergic neurons could be studied with Gal4/UAS:TeTx transgenic 
zebrafish.  
We showed that the dark-flash response was mediated by hrh1 and therefore hrh1 
knockouts could in future experiments be studied to verify the results of the 
pharmacological experiments. Interestingly, increased serotonin turnover was 
detected in the brainstem of hdc (Dere et al. 2004) and hrh1 knockout mice (Yanai 
et al. 1998). When extrapolated to zebrafish, this could provide a link between the 
two neuronal circuits that we identified. Therefore, the serotonin turnover could 
be assessed in animals treated with the hrh1 antagonist pyrilamine. Since hrh1 
antagonism affected the hcrt neurons, this system should be studied in both hdc 
and hrh1 knockouts. The fact that histamine affects the development of the hcrt 
neurons allows studies of the role of histamine in development and etiology of 
narcolepsy. As pointed out earlier, a mutation in hdc was associated with 
Tourette’s syndrome (Ercan-Sencicek et al. 2010) and we found that lack of hdc 
abolished the dark-induced flash response in zebrafish larvae. Taken together, 
these results, the responsiveness to changes in the environment in zebrafish and 
fine-tuning of the motor responses, appear to be mediated at least partially via the 
histaminergic neurotransmitter system. Furthermore, these results indicate that 
histamine could be needed for fine-tuning of motor functions, since Tourette’s 
syndrome patients suffer from involuntary uncontrolled small muscle contractions, 
i.e. tics. Therefore, it would be important to study the role of the histaminergic 
neurotransmitter system in prepulse inhibition and the startle response in 
zebrafish larvae. Since the startle response is driven by Mauthner neurons, the 
innervation of histaminergic neuron projections of the Mauthner neurons needs to 
be determined before the behavioral studies are conducted.  
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Since psen1 knockout affects the developing histaminergic system, the effect of 
this mutation could also disturb the hcrt system. A consensus of increased 
incidence of narcolepsy in AD patients is not available, since the two studies 
conducted reported contrasting results (Fronczek et al. 2011, Scammell et al. 
2011). The effect that psen1 knockout has on cell proliferation in rodents has not 
been reported for zebrafish. Therefore, the effect of histaminergic ligands on 
behavior and proliferation in psen1-/- and WT zebrafish should be determined. 
Finally, we reported that inhibition of γ-secretase with DAPT reduced the 
histamine neuron number. In zebrafish, DAPT mainly affects the ability of γ-
secretase to cleave Notch (Geling et al. 2002), and studying the histaminergic 
neurotransmitter system in Notch mutants would give a definite answer on 
whether or not the impaired development of histaminergic neurons is Notch-
mediated.  
Taken together, the results acquired from the pharmacological and transient 
knockdown approaches should be verified in stable knockout zebrafish models. 
The novel mechanistic findings should further be validated in other model 
organisms and humans, to eventually be able to draw conclusions applicable to 
humans, based on these specific findings. 
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